<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS Med</journal-id><journal-id journal-id-type="iso-abbrev">PLoS Med</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosmed</journal-id><journal-title-group><journal-title>PLoS Medicine</journal-title></journal-title-group><issn pub-type="ppub">1549-1277</issn><issn pub-type="epub">1549-1676</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29438414</article-id><article-id pub-id-type="pmc">5810983</article-id><article-id pub-id-type="doi">10.1371/journal.pmed.1002502</article-id><article-id pub-id-type="publisher-id">PMEDICINE-D-17-03180</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Physiological Parameters</subject><subj-group><subject>Body Weight</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Physiological Parameters</subject><subj-group><subject>Body Weight</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Public and Occupational Health</subject><subj-group><subject>Physical Activity</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Physiological Parameters</subject><subj-group><subject>Body Weight</subject><subj-group><subject>Weight Loss</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Physiological Parameters</subject><subj-group><subject>Body Weight</subject><subj-group><subject>Weight Loss</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Nutrition</subject><subj-group><subject>Diet</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Nutrition</subject><subj-group><subject>Diet</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Physiological Parameters</subject><subj-group><subject>Body Weight</subject><subj-group><subject>Obesity</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Physiological Parameters</subject><subj-group><subject>Body Weight</subject><subj-group><subject>Obesity</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Hormones</subject><subj-group><subject>Thyroid Hormones</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Hormones</subject><subj-group><subject>Peptide Hormones</subject><subj-group><subject>Leptin</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Nutrition</subject><subj-group><subject>Diet</subject><subj-group><subject>Alcohol Consumption</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Nutrition</subject><subj-group><subject>Diet</subject><subj-group><subject>Alcohol Consumption</subject></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Perfluoroalkyl substances and changes in body weight and resting metabolic rate in response to weight-loss diets: A prospective study</article-title><alt-title alt-title-type="running-head">Perfluoroalkyl Substances and Body Weight Change</alt-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-1430-3016</contrib-id><name><surname>Liu</surname><given-names>Gang</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Writing &#x02013; original draft</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-6397-7009</contrib-id><name><surname>Dhana</surname><given-names>Klodian</given-names></name><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Furtado</surname><given-names>Jeremy D.</given-names></name><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-5848-2987</contrib-id><name><surname>Rood</surname><given-names>Jennifer</given-names></name><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-0372-8262</contrib-id><name><surname>Zong</surname><given-names>Geng</given-names></name><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Liang</surname><given-names>Liming</given-names></name><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff003"><sup>3</sup></xref><xref ref-type="aff" rid="aff004"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Qi</surname><given-names>Lu</given-names></name><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff005"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Bray</surname><given-names>George A.</given-names></name><role content-type="http://credit.casrai.org/">Funding acquisition</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>DeJonge</surname><given-names>Lilian</given-names></name><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Coull</surname><given-names>Brent</given-names></name><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff004"><sup>4</sup></xref><xref ref-type="aff" rid="aff006"><sup>6</sup></xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-4046-9658</contrib-id><name><surname>Grandjean</surname><given-names>Philippe</given-names></name><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff006"><sup>6</sup></xref><xref ref-type="aff" rid="aff007"><sup>7</sup></xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-8480-1563</contrib-id><name><surname>Sun</surname><given-names>Qi</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Funding acquisition</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Supervision</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff008"><sup>8</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib></contrib-group><aff id="aff001"><label>1</label>
<addr-line>Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America</addr-line></aff><aff id="aff002"><label>2</label>
<addr-line>Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, Louisiana, United States of America</addr-line></aff><aff id="aff003"><label>3</label>
<addr-line>Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America</addr-line></aff><aff id="aff004"><label>4</label>
<addr-line>Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America</addr-line></aff><aff id="aff005"><label>5</label>
<addr-line>Department of Epidemiology, School of Public Health and Tropical Medicine, Tulane University, New Orleans, Louisiana, United States of America</addr-line></aff><aff id="aff006"><label>6</label>
<addr-line>Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America</addr-line></aff><aff id="aff007"><label>7</label>
<addr-line>Institute of Public Health, University of Southern Denmark, Odense, Denmark</addr-line></aff><aff id="aff008"><label>8</label>
<addr-line>Channing Division of Network Medicine, Department of Medicine, Brigham and Women&#x02019;s Hospital and Harvard Medical School, Boston, Massachusetts, United States of America</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Basu</surname><given-names>Sanjay</given-names></name><role>Academic Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>Stanford University, UNITED STATES</addr-line></aff><author-notes><fn fn-type="COI-statement" id="coi001"><p>We have read the journal's policy and the authors of this manuscript have the following competing interests: PG serves as a paid expert for the State of Minnesota in a forthcoming trial regarding environmental pollution with perfluorinated compounds.</p></fn><corresp id="cor001">* E-mail: <email>qisun@hsph.harvard.edu</email></corresp></author-notes><pub-date pub-type="epub"><day>13</day><month>2</month><year>2018</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2018</year></pub-date><volume>15</volume><issue>2</issue><elocation-id>e1002502</elocation-id><history><date date-type="received"><day>6</day><month>9</month><year>2017</year></date><date date-type="accepted"><day>9</day><month>1</month><year>2018</year></date></history><permissions><copyright-statement>&#x000a9; 2018 Liu et al</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Liu et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pmed.1002502.pdf"/><abstract><sec id="sec001"><title>Background</title><p>The potential endocrine-disrupting effects of perfluoroalkyl substances (PFASs) have been demonstrated in animal studies, but whether PFASs may interfere with body weight regulation in humans is largely unknown. This study aimed to examine the associations of PFAS exposure with changes in body weight and resting metabolic rate (RMR) in a diet-induced weight-loss setting.</p></sec><sec id="sec002"><title>Methods and findings</title><p>In the 2-year POUNDS Lost randomized clinical trial based in Boston, Massachusetts, and Baton Rouge, Louisiana, that examined the effects of energy-restricted diets on weight changes, baseline plasma concentrations of major PFASs were measured among 621 overweight and obese participants aged 30&#x02013;70 years. Body weight was measured at baseline and 6, 12, 18, and 24 months. RMR and other metabolic parameters, including glucose, lipids, thyroid hormones, and leptin, were measured at baseline and 6 and 24 months. Participants lost an average of 6.4 kg of body weight during the first 6 months (weight-loss period) and subsequently regained an average of 2.7 kg of body weight during the period of 6&#x02013;24 months (weight regain period). After multivariate adjustment, baseline PFAS concentrations were not significantly associated with concurrent body weight or weight loss during the first 6 months. In contrast, higher baseline levels of PFASs were significantly associated with a greater weight regain, primarily in women. In women, comparing the highest to the lowest tertiles of PFAS concentrations, the multivariate-adjusted mean weight regain (SE) was 4.0 (0.8) versus 2.1 (0.9) kg for perfluorooctanesulfonic acid (PFOS) (<italic>P</italic><sub>trend</sub> = 0.01); 4.3 (0.9) versus 2.2 (0.8) kg for perfluorooctanoic acid (PFOA) (<italic>P</italic><sub>trend</sub> = 0.007); 4.7 (0.9) versus 2.5 (0.9) kg for perfluorononanoic acid (PFNA) (<italic>P</italic><sub>trend</sub> = 0.006); 4.9 (0.9) versus 2.7 (0.8) kg for perfluorohexanesulfonic acid (PFHxS) (<italic>P</italic><sub>trend</sub> = 0.009); and 4.2 (0.8) versus 2.5 (0.9) kg for perfluorodecanoic acid (PFDA) (<italic>P</italic><sub>trend</sub> = 0.03). When further adjusted for changes in body weight or thyroid hormones during the first 6 months, results remained similar. Moreover, higher baseline plasma PFAS concentrations, especially for PFOS and PFNA, were significantly associated with greater decline in RMR during the weight-loss period and less increase in RMR during the weight regain period in both men and women. Limitations of the study include the possibility of unmeasured or residual confounding by socioeconomic and psychosocial factors, as well as possible relapse to the usual diet prior to randomization, which could have been rich in foods contaminated by PFASs through food packaging and also dense in energy.</p></sec><sec id="sec003"><title>Conclusions</title><p>In this diet-induced weight-loss trial, higher baseline plasma PFAS concentrations were associated with a greater weight regain, especially in women, possibly explained by a slower regression of RMR levels. These data illustrate a potential novel pathway through which PFASs interfere with human body weight regulation and metabolism. The possible impact of environmental chemicals on the obesity epidemic therefore deserves attention.</p></sec><sec id="sec004"><title>Trial registration</title><p>ClinicalTrials.gov <ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT00072995">NCT00072995</ext-link></p></sec></abstract><abstract abstract-type="toc"><p>Gang Liu and colleagues reveal that perfluoroalkyl substances, often found in food packaging particularly of energy dense foods, contribute to weight regain for those recruited to a weight loss trial. This effect is higher in women.</p></abstract><abstract abstract-type="summary"><title>Author summary</title><sec id="sec005"><title>Why was this study done?</title><list list-type="bullet"><list-item><p>Although many approaches can be used to achieve a short-term weight loss, maintenance of weight loss has become a key challenge for sustaining long-term benefits of weight loss. Accumulating evidence has suggested that certain environmental compounds may play an important role in weight gain and obesity development.</p></list-item><list-item><p>The potential endocrine-disrupting effects of perfluoroalkyl substances (PFASs) have been demonstrated in animal studies, but whether PFASs may interfere with body weight regulation in humans is largely unknown.</p></list-item></list></sec><sec id="sec006"><title>What did the researchers do and find?</title><list list-type="bullet"><list-item><p>In a 2-year diet-induced weight-loss trial (the POUNDS Lost trial), we measured plasma concentrations of PFASs at baseline in 621 overweight and obese men and women and collected information on changes in body weight, resting metabolic rate (RMR), and other metabolic parameters during weight loss and weight regain over the 2 years the participants were on the study diet.</p></list-item><list-item><p>Higher baseline levels of PFASs were significantly associated with a greater weight regain, primarily in women. On average, women in the highest tertile of PFAS concentrations regained 1.7&#x02013;2.2 kg more body weight than women in the lowest tertile.</p></list-item><list-item><p>Higher baseline plasma concentrations of PFASs, especially perfluorooctanesulfonic acid (PFOS) and perfluorononanoic acid (PFNA), were significantly associated with greater decline in RMR during the first 6 months and less increase in RMR during the period when participants on average regained weight (6&#x02013;24 months).</p></list-item></list></sec><sec id="sec007"><title>What do these findings mean?</title><list list-type="bullet"><list-item><p>In this diet-induced weight-loss trial, higher baseline PFAS concentrations were associated with a greater weight regain, especially in women, possibly explained by a slower return of RMR levels. These data provide initial evidence suggesting that PFASs may interfere with human body weight regulation and counteract efforts to maintain weight loss in adults.</p></list-item></list></sec></abstract><funding-group><award-group id="award001"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000066</institution-id><institution>National Institute of Environmental Health Sciences</institution></institution-wrap></funding-source><award-id>ES022981, ES021372, and ES021477</award-id></award-group><award-group id="award002"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000050</institution-id><institution>National Heart, Lung, and Blood Institute</institution></institution-wrap></funding-source><award-id>HL073286</award-id></award-group><award-group id="award003"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>RR-02635</award-id></award-group><funding-statement>This research was supported by NIH grants from the National Institute for Environmental Health Sciences (ES022981, ES021372, and ES021477), the National Heart, Lung, and Blood Institute (HL073286), and the General Clinical Research Center, National Institutes of Health (RR-02635). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="2"/><table-count count="4"/><page-count count="21"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All relevant data are within the paper and its Supporting Information files.</p></notes></front><body><sec sec-type="intro" id="sec008"><title>Introduction</title><p>Obesity has become a worldwide public health concern [<xref rid="pmed.1002502.ref001" ref-type="bibr">1</xref>,<xref rid="pmed.1002502.ref002" ref-type="bibr">2</xref>]. Based on recent US data, the prevalence of obesity is 37.7% in adults and 17.0% in children and adolescents, with no sign of a reduction in the foreseeable future [<xref rid="pmed.1002502.ref003" ref-type="bibr">3</xref>&#x02013;<xref rid="pmed.1002502.ref005" ref-type="bibr">5</xref>]. Although many approaches can be used to achieve short-term weight loss, its maintenance remains a key challenge [<xref rid="pmed.1002502.ref006" ref-type="bibr">6</xref>,<xref rid="pmed.1002502.ref007" ref-type="bibr">7</xref>]. Meanwhile, given the same intervention strategies, apparent within-group variability in weight loss and weight regain has been demonstrated [<xref rid="pmed.1002502.ref007" ref-type="bibr">7</xref>,<xref rid="pmed.1002502.ref008" ref-type="bibr">8</xref>]. Although the exact reasons for the variability are largely unknown, accumulating evidence has suggested that certain environmental compounds may play an important role in weight gain and obesity development [<xref rid="pmed.1002502.ref009" ref-type="bibr">9</xref>,<xref rid="pmed.1002502.ref010" ref-type="bibr">10</xref>].</p><p>Perfluoroalkyl substances (PFASs), especially perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS), have been identified as plausible endocrine disruptors with the potential to perturb weight regulation [<xref rid="pmed.1002502.ref009" ref-type="bibr">9</xref>,<xref rid="pmed.1002502.ref011" ref-type="bibr">11</xref>&#x02013;<xref rid="pmed.1002502.ref014" ref-type="bibr">14</xref>]. Evidence from animal studies has suggested that PFASs may be involved in altering energy metabolism and thyroid hormone homeostasis [<xref rid="pmed.1002502.ref015" ref-type="bibr">15</xref>&#x02013;<xref rid="pmed.1002502.ref017" ref-type="bibr">17</xref>], likely through the activation of various transcriptional factors, such as the peroxisome proliferator-activated receptors (PPARs) [<xref rid="pmed.1002502.ref018" ref-type="bibr">18</xref>&#x02013;<xref rid="pmed.1002502.ref020" ref-type="bibr">20</xref>]. However, given the species-specific toxicokinetics and tissue distribution of PFASs [<xref rid="pmed.1002502.ref018" ref-type="bibr">18</xref>], extrapolation from animals to humans has yet to be supported. Although some human studies have examined the potential intergenerational effects of PFASs on body weight, the findings were somewhat inconsistent [<xref rid="pmed.1002502.ref021" ref-type="bibr">21</xref>&#x02013;<xref rid="pmed.1002502.ref027" ref-type="bibr">27</xref>]. To our knowledge, no prospective study has explored the association between PFAS exposure and weight change in adults under controlled circumstances. Furthermore, it is largely unknown whether resting metabolic rate (RMR) or thyroid hormones, factors that can influence energy expenditure [<xref rid="pmed.1002502.ref028" ref-type="bibr">28</xref>], might be also involved in the potential effects of PFASs on weight regulation [<xref rid="pmed.1002502.ref029" ref-type="bibr">29</xref>,<xref rid="pmed.1002502.ref030" ref-type="bibr">30</xref>].</p><p>PFASs are extensively used in many industrial and consumer products, including food packaging, paper and textile coatings, and non-stick cookware [<xref rid="pmed.1002502.ref031" ref-type="bibr">31</xref>&#x02013;<xref rid="pmed.1002502.ref034" ref-type="bibr">34</xref>]. A recent study reported that the drinking water supplies for at least 6 million US citizens may exceed the US Environmental Protection Agency&#x02019;s health advisory limit for lifetime exposure to PFOS and PFOA from drinking water [<xref rid="pmed.1002502.ref035" ref-type="bibr">35</xref>]. In addition, these compounds are extremely stable in the environment and have a long elimination half-life in the human body [<xref rid="pmed.1002502.ref036" ref-type="bibr">36</xref>], thus rendering PFASs a possible threat to human health. Due to the potential metabolic abnormalities associated with elevated PFAS levels, we aimed to examine the associations of PFAS exposure with changes in body weight and RMR in the well-designed and rigorously conducted POUNDS (Preventing Overweight Using Novel Dietary Strategies) Lost trial [<xref rid="pmed.1002502.ref037" ref-type="bibr">37</xref>].</p></sec><sec sec-type="materials|methods" id="sec009"><title>Methods</title><sec id="sec010"><title>Ethics statement</title><p>The protocol was approved by the institutional review boards at the Harvard T.H. Chan School of Public Health, Brigham and Women&#x02019;s Hospital, and the Pennington Biomedical Research Center of the Louisiana State University System, as well as by a data and safety monitoring board appointed by the National Heart, Lung, and Blood Institute. All participants provided written informed consent. The trial was registered at ClinicalTrials.gov (NCT00072995).</p></sec><sec id="sec011"><title>Study participants</title><p>The POUNDS Lost study, a 2-year randomized clinical trial, was designed to compare the effects of 4 energy-reduced diets with different macronutrient (i.e., fat, protein, and carbohydrate) compositions on body weight, as previously described [<xref rid="pmed.1002502.ref037" ref-type="bibr">37</xref>]. At baseline, 811 overweight and obese men and women aged 30&#x02013;70 years were randomly assigned to 1 of 4 diets that consisted of different compositions of similar foods and met the guidelines for cardiovascular health. Eighty percent of the participants (<italic>n =</italic> 645) completed the trial. Each participant&#x02019;s caloric prescription for the 2-year period represented a deficit of 750 kcal per day from baseline, as calculated from each individual&#x02019;s resting energy expenditure and activity level [<xref rid="pmed.1002502.ref037" ref-type="bibr">37</xref>]. All participants had normal thyroid function at study baseline [<xref rid="pmed.1002502.ref038" ref-type="bibr">38</xref>]. The main findings of this trial were that most of the weight loss was observed in the first 6 months, followed by a gradual weight regain through to 24 months, and that the weight changes (both weight loss and weight regain) did not differ significantly between the diet groups [<xref rid="pmed.1002502.ref037" ref-type="bibr">37</xref>].</p><p>The current analysis included 621 participants with available fasting plasma samples collected at baseline. Of these individuals, 592 and 460 participants also provided blood samples at 6 months and 2 years, respectively.</p></sec><sec id="sec012"><title>Measurements of anthropometry and RMR</title><p>In the morning before breakfast and after urination, body weight and waist circumference were measured at baseline and 6, 12, 18, and 24 months. Body mass index (BMI) was calculated as body weight in kilograms divided by height in meters squared. At baseline and 6 and 24 months, body fat mass and lean mass (<italic>n =</italic> 424) were measured using dual energy X-ray absorptiometry (DXA) (Hologic QDR 4500A bone densitometer; Hologic); visceral and subcutaneous abdominal fat (<italic>n =</italic> 165) were measured using a computed tomography (CT) scanner [<xref rid="pmed.1002502.ref039" ref-type="bibr">39</xref>]; and blood pressure was measured by an automated device (Omron HEM907XL; Omron). RMR was assessed at baseline and 6 and 24 months using a Deltatrac II Metabolic Monitor (Datex-Ohmeda) after an overnight fast [<xref rid="pmed.1002502.ref040" ref-type="bibr">40</xref>]. Briefly, after a 30-minute rest, a transparent plastic hood was placed over the head of the participant for another 30 minutes. Participants were required to keep still and awake during the test, and the last 20 minutes of measurements were used for the calculation of RMR [<xref rid="pmed.1002502.ref040" ref-type="bibr">40</xref>].</p></sec><sec id="sec013"><title>Laboratory measurements of PFASs and other metabolic markers</title><p>Plasma concentrations of PFOS, PFOA, perfluorononanoic acid (PFNA), perfluorohexanesulfonic acid (PFHxS), and perfluorodecanoic acid (PFDA) were measured at baseline only, using a sensitive and reliable method based on online solid phase extraction and liquid chromatography coupled to a triple quadropole mass spectrometer [<xref rid="pmed.1002502.ref041" ref-type="bibr">41</xref>], with minor modifications. Due to the long elimination half-lives of the PFASs and incomplete samplings, we did not measure plasma PFAS levels during the trial. For all major PFASs, the concentrations were above the limit of detection (0.05 ng/ml), and the inter- and intra-assay coefficients of variation were &#x0003c;6.3% and &#x0003c;6.1%, respectively.</p><p>In our pilot study evaluating the within-person stability of PFAS concentrations, intra-class correlation coefficients (ICCs) between concentrations in 2 blood samples collected 1&#x02013;2 years apart from 58 participants in the Nurses&#x02019; Health Study II demonstrated excellent reproducibility of PFAS concentrations in blood: the ICCs were 0.91 for PFOS, 0.90 for PFOA, 0.94 for PFHxS, 0.87 for PFNA, and 0.82 for PFDA (all <italic>P &#x0003c;</italic> 0.001).</p><p>At baseline, 6 months, and 24 months, fasting plasma glucose, insulin, total cholesterol, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, and triglycerides were measured on the Synchron CX7 (Beckman Coulter), and hemoglobin A1C (HbA1c) was measured on a Synchron CX5 (Beckman Coulter); plasma leptin and soluble leptin receptor were measured by an ultrasensitive immunoassay (R&#x00026;D Systems); and serum free triiodothyronine (T3), free thyroxine (T4), total T3, total T4, and thyroid stimulating hormone were measured using a competitive electrochemiluminescence immunoassay on the Roche E modular system (Roche Diagnostics), as previously described elsewhere [<xref rid="pmed.1002502.ref037" ref-type="bibr">37</xref>]. The homeostatic model assessment of insulin resistance (HOMA-IR) value was calculated using the updated HOMA model (HOMA2) described by Levy et al. [<xref rid="pmed.1002502.ref042" ref-type="bibr">42</xref>]. Adipose tissue was obtained from 103 participants at baseline and at 6 months. Gene expression was measured by direct hybridization using the Illumina HumanHT-12 v3 Expression BeadChip (Illumina) (details in <xref ref-type="supplementary-material" rid="pmed.1002502.s007">S1 Text</xref>).</p></sec><sec id="sec014"><title>Assessments of other covariates</title><p>Using standardized questionnaires, we obtained information on age, sex, race (white, black, Hispanic, or other), educational attainment (high school or less, some college, or college graduate or beyond), smoking status (never, former, or current smoker), alcohol consumption (drinks/week), menopausal status (yes or no), and hormone replacement therapy use (yes or no). At baseline, 6 months, and 24 months, physical activity was assessed using the Baecke physical activity questionnaire, which included 16 items inquiring about levels of habitual physical activities (i.e., physical activity at work, sports during leisure time, and other physical activity during leisure time) [<xref rid="pmed.1002502.ref043" ref-type="bibr">43</xref>]. All responses were pre-coded on 5-point scales. Total physical activity was expressed as the average of the sum of the individual responses, with a score ranging from 0 to 5 [<xref rid="pmed.1002502.ref043" ref-type="bibr">43</xref>].</p></sec><sec id="sec015"><title>Statistical analysis</title><p>The comparisons between participants included in the current analysis and those excluded were evaluated by the Student&#x02019;s <italic>t</italic> test for normally distributed variables, the Wilcoxon rank-sum test for skewed variables, and the chi-squared test for categorical variables. The associations between baseline PFASs and changes in body weight and RMR during the period of weight loss (first 6 months) or weight regain (6&#x02013;24 months) were examined using linear regression. The least-square means of changes in body weight (at 6, 12, 18, and 24 months) and RMR (at 6 and 24 months) according to tertiles of baseline PFAS concentrations were calculated. In addition, the relationship between PFASs and other potential mediators including thyroid hormones and leptin were further evaluated using linear regression. Covariates considered in multivariate adjustments included baseline age (continuous), sex, race, educational attainment (high school or less, some college, or college graduate or beyond), smoking status (never, former, or current smoker), alcohol consumption (continuous), physical activity (continuous), the 4 diet groups, and baseline BMI (or baseline RMR for the analysis of RMR change). Moreover, menopausal status and hormone replacement therapy (women only) were also entered into the model in a sensitivity analysis. To test the linear trend of the associations of baseline PFAS concentrations with changes in body weight and RMR, we assigned a median value to each tertile of PFAS concentration and treated it as a continuous variable. We also tested the linear trend using the PFAS concentrations as continuous variables (log<sub>10</sub>-transformed). In an exploratory analysis, factor analysis was used to explore the potential exposure patterns of PFASs.</p><p>To investigate the associations of baseline PFASs with baseline values of and changes in other metabolic parameters (including glucose, lipids, thyroid hormones, and leptin), Spearman correlation coefficients (<italic>r</italic><sub>s</sub>) were calculated with adjustment for the potential confounders mentioned above. Stratified analysis was also conducted according to sex, and a likelihood ratio test was performed to test for potential interactions. In sensitivity analyses, body weight or RMR at 6 months (or changes during the first 6 months), instead of the baseline value, was included in the multivariate models when examining the associations between baseline PFASs and changes in body weight or RMR during the period of 6&#x02013;24 months. We also stratified the analyses by dietary intervention group. In addition, to account for the correlations between measurements on the same individuals, linear mixed-effects models were also used to examine the associations between baseline PFAS concentrations and weight regain (weight measurements at 6, 12, 18, and 24 months), with an unstructured covariance matrix. To assess confounding patterns, in another sensitivity analysis, the covariates were entered into the model in a stepwise manner. In an exploratory analysis, we also examined the associations of PFAS exposures with the gene expression profile in adipose tissue (<xref ref-type="supplementary-material" rid="pmed.1002502.s007">S1 Text</xref>).</p><p>A 2-sided <italic>P</italic> &#x0003c; 0.05 was considered statistically significant. The statistical analyses were performed with SAS software, version 9.4 (SAS Institute).</p></sec></sec><sec sec-type="results" id="sec016"><title>Results</title><sec id="sec017"><title>Study population</title><p>The mean (SD) age of the 621 participants was 51.4 (9.1) years, with a mean (SD) baseline BMI of 32.6 (3.8) kg/m<sup>2</sup>. Participants lost an average of 6.4 kg of body weight during the first 6 months and subsequently regained an average of 2.7 kg during the remaining study period. In comparison with the POUNDS Lost participants not included in the current study due to the lack of plasma samples at baseline, the participants included were slightly older (51.4 versus 49.1 years, <italic>P</italic> = 0.01), but there were no significant differences in other characteristics, including body weight and RMR (<xref ref-type="supplementary-material" rid="pmed.1002502.s002">S1 Table</xref>).</p></sec><sec id="sec018"><title>Associations between PFASs, body weight, and other metabolic parameters at baseline</title><p><xref ref-type="table" rid="pmed.1002502.t001">Table 1</xref> shows the baseline characteristics of the study participants. PFOS and PFOA were the dominant PFASs. The median (interquartile range) plasma concentration was 24.5 (16.2&#x02013;37.0) ng/ml for PFOS, 4.5 (3.3&#x02013;6.3) ng/ml for PFOA, 2.4 (1.5&#x02013;3.6) ng/ml for PFHxS, 1.5 (1.0&#x02013;2.4) ng/ml for PFNA, and 0.37 (0.27&#x02013;0.52) ng/ml for PFDA. At baseline, significant inter-correlations were observed between PFOS, PFOA, PFHxS, PFNA, and PFDA (<italic>r</italic><sub>s</sub> ranged from 0.38 to 0.85) (<xref ref-type="supplementary-material" rid="pmed.1002502.s003">S2 Table</xref>), although no particular pattern of PFAS mixture was identified in the factor analysis. After multivariate adjustment, PFOS, PFOA, and PFNA concentration were all positively associated with insulin, HOMA-IR, diastolic blood pressure, and free T3 (<italic>r</italic><sub>s</sub> ranged from 0.10 to 0.18, all <italic>P &#x0003c;</italic> 0.05) at baseline. In addition, certain PFASs (e.g., PFHxS and PFDA) were positively associated with some of the variables, including visceral fat mass, systolic blood pressure, glucose, triglycerides, LDL cholesterol, free T4, total T4, and leptin (<italic>r</italic><sub>s</sub> ranged from 0.08 to 0.24, all <italic>P &#x0003c;</italic> 0.05) (<xref ref-type="supplementary-material" rid="pmed.1002502.s003">S2 Table</xref>). No PFASs were correlated with body weight, waist circumference, BMI, or RMR at baseline.</p><table-wrap id="pmed.1002502.t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pmed.1002502.t001</object-id><label>Table 1</label><caption><title>Baseline characteristics of participating men and women.</title></caption><alternatives><graphic id="pmed.1002502.t001g" xlink:href="pmed.1002502.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Characteristic</th><th align="left" rowspan="1" colspan="1">Men (<italic>n =</italic> 237)</th><th align="left" rowspan="1" colspan="1">Women (<italic>n =</italic> 384)</th><th align="left" rowspan="1" colspan="1"><italic>P</italic>-value<xref ref-type="table-fn" rid="t001fn002"><sup>a</sup></xref></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age (years)</td><td align="left" rowspan="1" colspan="1">51.9 &#x000b1; 9.6</td><td align="left" rowspan="1" colspan="1">51.1 &#x000b1; 8.8</td><td align="left" rowspan="1" colspan="1">0.26</td></tr><tr><td align="left" rowspan="1" colspan="1">Race white</td><td align="left" rowspan="1" colspan="1">89.9%</td><td align="left" rowspan="1" colspan="1">74.7%</td><td align="left" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</td><td align="left" rowspan="1" colspan="1">33.4 &#x000b1; 3.4</td><td align="left" rowspan="1" colspan="1">32.0 &#x000b1; 3.9</td><td align="left" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Weight (kg)</td><td align="left" rowspan="1" colspan="1">104.1 &#x000b1; 12.7</td><td align="left" rowspan="1" colspan="1">85.7 &#x000b1; 12.6</td><td align="left" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Waist circumference (cm)</td><td align="left" rowspan="1" colspan="1">113.2 &#x000b1; 10.1</td><td align="left" rowspan="1" colspan="1">97.2 &#x000b1; 10.9</td><td align="left" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Resting metabolic rate (kcal/24 h)</td><td align="left" rowspan="1" colspan="1">1,821.9 &#x000b1; 243.6</td><td align="left" rowspan="1" colspan="1">1,378.6 &#x000b1; 184.6</td><td align="left" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Education level</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">0.19</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;High school or less</td><td align="left" rowspan="1" colspan="1">11.0%</td><td align="left" rowspan="1" colspan="1">9.0%</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Some college</td><td align="left" rowspan="1" colspan="1">17.3%</td><td align="left" rowspan="1" colspan="1">23.2%</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;College graduate or beyond</td><td align="left" rowspan="1" colspan="1">71.7%</td><td align="left" rowspan="1" colspan="1">61.8%</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Smoking status</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">0.006</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Never smoked</td><td align="left" rowspan="1" colspan="1">51.9%</td><td align="left" rowspan="1" colspan="1">64.9%</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Past smoker</td><td align="left" rowspan="1" colspan="1">43.9%</td><td align="left" rowspan="1" colspan="1">32.0%</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Current smoker</td><td align="left" rowspan="1" colspan="1">4.2%</td><td align="left" rowspan="1" colspan="1">3.1%</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Alcohol consumption (drinks/week)</td><td align="left" rowspan="1" colspan="1">2.0 (0&#x02013;5.0)</td><td align="left" rowspan="1" colspan="1">1.0 (0&#x02013;2.0)</td><td align="left" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Physical activity<xref ref-type="table-fn" rid="t001fn003"><sup>b</sup></xref></td><td align="left" rowspan="1" colspan="1">1.60 &#x000b1; 0.1</td><td align="left" rowspan="1" colspan="1">1.56 &#x000b1; 0.1</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Systolic blood pressure (mm Hg)</td><td align="left" rowspan="1" colspan="1">124.0 &#x000b1; 12.2</td><td align="left" rowspan="1" colspan="1">117.0 &#x000b1; 13.7</td><td align="left" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Diastolic blood pressure (mm Hg)</td><td align="left" rowspan="1" colspan="1">77.7 &#x000b1; 9.1</td><td align="left" rowspan="1" colspan="1">74.0 &#x000b1; 8.9</td><td align="left" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Glucose (mmol/l)</td><td align="left" rowspan="1" colspan="1">5.2 (4.9&#x02013;5.5)</td><td align="left" rowspan="1" colspan="1">4.9 (4.6&#x02013;5.1)</td><td align="left" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Insulin (pmol/l)<xref ref-type="table-fn" rid="t001fn004"><sup>c</sup></xref></td><td align="left" rowspan="1" colspan="1">84.7 (61.1&#x02013;117.4)</td><td align="left" rowspan="1" colspan="1">63.9 (45.1&#x02013;101.4)</td><td align="left" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Total cholesterol (mmol/l)</td><td align="left" rowspan="1" colspan="1">5.9 (4.8&#x02013;8.5)</td><td align="left" rowspan="1" colspan="1">5.6 (4.8&#x02013;6.8)</td><td align="left" rowspan="1" colspan="1">0.002</td></tr><tr><td align="left" rowspan="1" colspan="1">LDL cholesterol (mmol/l)</td><td align="left" rowspan="1" colspan="1">3.1 (2.6&#x02013;3.7)</td><td align="left" rowspan="1" colspan="1">3.3 (2.8&#x02013;3.8)</td><td align="left" rowspan="1" colspan="1">0.003</td></tr><tr><td align="left" rowspan="1" colspan="1">HDL cholesterol (mmol/l)</td><td align="left" rowspan="1" colspan="1">1.0 (0.9&#x02013;1.2)</td><td align="left" rowspan="1" colspan="1">1.3 (1.1&#x02013;1.6)</td><td align="left" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Triglycerides (mmol/l)</td><td align="left" rowspan="1" colspan="1">2.0 &#x000b1; 1.1</td><td align="left" rowspan="1" colspan="1">1.4 &#x000b1; 0.8</td><td align="left" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Free T3 (pmol/l)<xref ref-type="table-fn" rid="t001fn005"><sup>d</sup></xref></td><td align="left" rowspan="1" colspan="1">5.2 (4.8&#x02013;5.5)</td><td align="left" rowspan="1" colspan="1">4.8 (4.4&#x02013;5.1)</td><td align="left" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Free T4 (pmol/l)<xref ref-type="table-fn" rid="t001fn005"><sup>d</sup></xref></td><td align="left" rowspan="1" colspan="1">15.3 (14.1&#x02013;16.2)</td><td align="left" rowspan="1" colspan="1">14.8 (13.5&#x02013;16.2)</td><td align="left" rowspan="1" colspan="1">0.002</td></tr><tr><td align="left" rowspan="1" colspan="1">PFOS (ng/ml)</td><td align="left" rowspan="1" colspan="1">27.2 (19.9&#x02013;45.2)</td><td align="left" rowspan="1" colspan="1">22.3 (14.3&#x02013;34.9)</td><td align="left" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">PFOA (ng/ml)</td><td align="left" rowspan="1" colspan="1">5.2 (3.9&#x02013;6.8)</td><td align="left" rowspan="1" colspan="1">4.1 (2.8&#x02013;5.6)</td><td align="left" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">PFHxS (ng/ml)</td><td align="left" rowspan="1" colspan="1">3.1 (2.3&#x02013;4.4)</td><td align="left" rowspan="1" colspan="1">1.9 (1.2&#x02013;3.0)</td><td align="left" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">PFNA (ng/ml)</td><td align="left" rowspan="1" colspan="1">1.6 (1.1&#x02013;2.4)</td><td align="left" rowspan="1" colspan="1">1.5 (1.0&#x02013;2.4)</td><td align="left" rowspan="1" colspan="1">0.07</td></tr><tr><td align="left" rowspan="1" colspan="1">PFDA (ng/ml)</td><td align="left" rowspan="1" colspan="1">0.4 (0.3&#x02013;0.5)</td><td align="left" rowspan="1" colspan="1">0.4 (0.3&#x02013;0.6)</td><td align="left" rowspan="1" colspan="1">0.38</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t001fn001"><p>Data are mean &#x000b1; SD, median (interquartile range), or percentage.</p></fn><fn id="t001fn002"><p><sup>a</sup>The comparisons were examined using the Student&#x02019;s <italic>t</italic> test for normally distributed variables, the Wilcoxon rank-sum test for skewed variables, and the chi-squared test for categorical variables.</p></fn><fn id="t001fn003"><p><sup>b</sup>Physical activity was estimated by the Baecke questionnaire.</p></fn><fn id="t001fn004"><p><sup>c</sup>One participant had missing value for insulin.</p></fn><fn id="t001fn005"><p><sup>d</sup>In all, 30 men and 60 women had missing values for free T3 and free T4.</p></fn><fn id="t001fn006"><p>HDL, high-density lipoprotein; LDL, low-density lipoprotein; PFDA, perfluorodecanoic acid; PFHxS, perfluorohexanesulfonic acid; PFNA, perfluorononanoic acid; PFOA, perfluorooctanoic acid; PFOS, perfluorooctanesulfonic acid; T3, triiodothyronine; T4, thyroxine.</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec019"><title>Baseline PFASs and body weight changes</title><p>After multivariate adjustment including smoking status, physical activity, baseline BMI, and dietary intervention group, baseline PFAS concentrations were not associated with weight loss in the first 6 months (<xref ref-type="table" rid="pmed.1002502.t002">Table 2</xref>). The crude positive associations between certain PFAS levels and weight loss were abolished after multivariate adjustment (<xref ref-type="table" rid="pmed.1002502.t002">Table 2</xref>). In contrast, after multivariate adjustment, baseline PFOS and PFNA concentrations were positively associated with greater weight regain in the total study population. Comparing the highest to the lowest tertiles, the least-square means (SEs) of weight regain were 3.3 (0.6) versus 1.8 (0.6) kg for PFOS (<italic>P</italic><sub>trend</sub> = 0.009) and 3.4 (0.6) versus 2.0 (0.6) kg for PFNA (<italic>P</italic><sub>trend</sub> = 0.01) (Model 2 in <xref ref-type="table" rid="pmed.1002502.t002">Table 2</xref>). The results were similar when PFAS concentrations were treated as continuous variables (the beta coefficients for per-unit log<sub>10</sub>-transformed PFOS and PFNA increment were 0.80 and 1.02, respectively; both <italic>P</italic><sub>continuous</sub> &#x0003c; 0.05) (<xref ref-type="table" rid="pmed.1002502.t002">Table 2</xref>). After further adjusting for baseline thyroid hormones (Model 3 in <xref ref-type="table" rid="pmed.1002502.t002">Table 2</xref>), the associations remained significant. In sensitivity analyses, when body weight at baseline or 6 months (instead of BMI at baseline) was adjusted for in the models, the results were largely unchanged. When changes in body weight or changes in thyroid hormones or leptin during the first 6 months were also included as covariates, the results did not change materially. In addition, similar results were obtained when using linear mixed-effects models. When PFAS levels were categorized into quartiles, the results were largely similar.</p><table-wrap id="pmed.1002502.t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pmed.1002502.t002</object-id><label>Table 2</label><caption><title>Changes in body weight<xref ref-type="table-fn" rid="t002fn002"><sup>a</sup></xref> according to tertiles of PFAS concentrations.</title></caption><alternatives><graphic id="pmed.1002502.t002g" xlink:href="pmed.1002502.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="2" colspan="1">PFAS</th><th align="left" colspan="3" rowspan="1">Tertile of PFAS concentration (ng/ml)</th><th align="left" rowspan="2" colspan="1"><italic>P</italic><sub>trend</sub></th><th align="left" rowspan="2" colspan="1"><italic>P</italic><sub>continuous</sub><xref ref-type="table-fn" rid="t002fn003"><sup>b</sup></xref></th></tr><tr><th align="left" rowspan="1" colspan="1">Tertile 1</th><th align="left" rowspan="1" colspan="1">Tertile 2</th><th align="left" rowspan="1" colspan="1">Tertile 3</th></tr></thead><tbody><tr><td align="left" colspan="6" style="background-color:#FFFFFF" rowspan="1"><bold>Weight change (kg) during first 6 months; total <italic>n =</italic> 621</bold></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>PFOS</bold></td><td align="left" rowspan="1" colspan="1">&#x0003c;19.2</td><td align="left" rowspan="1" colspan="1">19.2&#x02013;32.1</td><td align="left" rowspan="1" colspan="1">&#x0003e;32.1</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Median (IQR)</td><td align="left" rowspan="1" colspan="1">13.3 (9.7&#x02013;16.2)</td><td align="left" rowspan="1" colspan="1">24.4 (21.4&#x02013;28.5)</td><td align="left" rowspan="1" colspan="1">47.1 (37.0&#x02013;58.8)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Model 1 (unadjusted)</td><td align="left" rowspan="1" colspan="1">&#x02212;5.2 &#x000b1; 0.4</td><td align="left" rowspan="1" colspan="1">&#x02212;7.1 &#x000b1; 0.4</td><td align="left" rowspan="1" colspan="1">&#x02212;7.0 &#x000b1; 0.4</td><td align="left" rowspan="1" colspan="1">0.01</td><td align="left" rowspan="1" colspan="1">0.02</td></tr><tr><td align="left" rowspan="1" colspan="1">Model 2</td><td align="left" rowspan="1" colspan="1">&#x02212;4.7 &#x000b1; 0.6</td><td align="left" rowspan="1" colspan="1">&#x02212;5.5 &#x000b1; 0.6</td><td align="left" rowspan="1" colspan="1">&#x02212;5.3 &#x000b1; 0.6</td><td align="left" rowspan="1" colspan="1">0.27</td><td align="left" rowspan="1" colspan="1">0.99</td></tr><tr><td align="left" rowspan="1" colspan="1">Model 3</td><td align="left" rowspan="1" colspan="1">&#x02212;5.0 &#x000b1; 0.6</td><td align="left" rowspan="1" colspan="1">&#x02212;5.7 &#x000b1; 0.6</td><td align="left" rowspan="1" colspan="1">&#x02212;5.3 &#x000b1; 0.6</td><td align="left" rowspan="1" colspan="1">0.63</td><td align="left" rowspan="1" colspan="1">0.59</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>PFOA</bold></td><td align="left" rowspan="1" colspan="1">&#x0003c;3.7</td><td align="left" rowspan="1" colspan="1">3.7&#x02013;5.5</td><td align="left" rowspan="1" colspan="1">&#x0003e;5.5</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Median (IQR)</td><td align="left" rowspan="1" colspan="1">2.8 (2.2&#x02013;3.4)</td><td align="left" rowspan="1" colspan="1">4.5 (4.1&#x02013;4.9)</td><td align="left" rowspan="1" colspan="1">7.1 (6.3&#x02013;8.3)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Model 1 (unadjusted)</td><td align="left" rowspan="1" colspan="1">&#x02212;5.7 &#x000b1; 0.4</td><td align="left" rowspan="1" colspan="1">&#x02212;6.6 &#x000b1; 0.4</td><td align="left" rowspan="1" colspan="1">&#x02212;6.9 &#x000b1; 0.4</td><td align="left" rowspan="1" colspan="1">0.05</td><td align="left" rowspan="1" colspan="1">0.02</td></tr><tr><td align="left" rowspan="1" colspan="1">Model 2</td><td align="left" rowspan="1" colspan="1">&#x02212;5.3 &#x000b1; 0.6</td><td align="left" rowspan="1" colspan="1">&#x02212;5.1 &#x000b1; 0.6</td><td align="left" rowspan="1" colspan="1">&#x02212;5.1 &#x000b1; 0.6</td><td align="left" rowspan="1" colspan="1">0.73</td><td align="left" rowspan="1" colspan="1">0.70</td></tr><tr><td align="left" rowspan="1" colspan="1">Model 3</td><td align="left" rowspan="1" colspan="1">&#x02212;5.5 &#x000b1; 0.6</td><td align="left" rowspan="1" colspan="1">&#x02212;5.4 &#x000b1; 0.6</td><td align="left" rowspan="1" colspan="1">&#x02212;5.0 &#x000b1; 0.6</td><td align="left" rowspan="1" colspan="1">0.41</td><td align="left" rowspan="1" colspan="1">0.39</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>PFHxS</bold></td><td align="left" rowspan="1" colspan="1">&#x0003c;1.8</td><td align="left" rowspan="1" colspan="1">1.8&#x02013;3.1</td><td align="left" rowspan="1" colspan="1">&#x0003e;3.1</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Median (IQR)</td><td align="left" rowspan="1" colspan="1">1.2 (0.8&#x02013;1.5)</td><td align="left" rowspan="1" colspan="1">2.4 (2.1&#x02013;2.7)</td><td align="left" rowspan="1" colspan="1">4.3 (3.6&#x02013;5.5)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Model 1 (unadjusted)</td><td align="left" rowspan="1" colspan="1">&#x02212;5.7 &#x000b1; 0.4</td><td align="left" rowspan="1" colspan="1">&#x02212;6.5 &#x000b1; 0.4</td><td align="left" rowspan="1" colspan="1">&#x02212;7.0 &#x000b1; 0.4</td><td align="left" rowspan="1" colspan="1">0.01</td><td align="left" rowspan="1" colspan="1">0.02</td></tr><tr><td align="left" rowspan="1" colspan="1">Model 2</td><td align="left" rowspan="1" colspan="1">&#x02212;5.3 &#x000b1; 0.6</td><td align="left" rowspan="1" colspan="1">&#x02212;5.1 &#x000b1; 0.6</td><td align="left" rowspan="1" colspan="1">&#x02212;5.1 &#x000b1; 0.6</td><td align="left" rowspan="1" colspan="1">0.76</td><td align="left" rowspan="1" colspan="1">0.45</td></tr><tr><td align="left" rowspan="1" colspan="1">Model 3</td><td align="left" rowspan="1" colspan="1">&#x02212;5.6 &#x000b1; 0.6</td><td align="left" rowspan="1" colspan="1">&#x02212;5.1 &#x000b1; 0.6</td><td align="left" rowspan="1" colspan="1">&#x02212;5.2 &#x000b1; 0.7</td><td align="left" rowspan="1" colspan="1">0.54</td><td align="left" rowspan="1" colspan="1">0.22</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>PFNA</bold></td><td align="left" rowspan="1" colspan="1">&#x0003c;1.1</td><td align="left" rowspan="1" colspan="1">1.1&#x02013;2.0</td><td align="left" rowspan="1" colspan="1">&#x0003e;2.0</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Median (IQR)</td><td align="left" rowspan="1" colspan="1">0.89 (0.74&#x02013;1.0)</td><td align="left" rowspan="1" colspan="1">1.5 (1.3&#x02013;1.7)</td><td align="left" rowspan="1" colspan="1">3.0 (2.4&#x02013;4.0)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Model 1 (unadjusted)</td><td align="left" rowspan="1" colspan="1">&#x02212;5.3 &#x000b1; 0.4</td><td align="left" rowspan="1" colspan="1">&#x02212;6.9 &#x000b1; 0.4</td><td align="left" rowspan="1" colspan="1">&#x02212;7.0 &#x000b1; 0.4</td><td align="left" rowspan="1" colspan="1">0.01</td><td align="left" rowspan="1" colspan="1">0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">Model 2</td><td align="left" rowspan="1" colspan="1">&#x02212;4.7 &#x000b1; 0.6</td><td align="left" rowspan="1" colspan="1">&#x02212;5.4 &#x000b1; 0.6</td><td align="left" rowspan="1" colspan="1">&#x02212;5.4 &#x000b1; 0.6</td><td align="left" rowspan="1" colspan="1">0.18</td><td align="left" rowspan="1" colspan="1">0.29</td></tr><tr><td align="left" rowspan="1" colspan="1">Model 3</td><td align="left" rowspan="1" colspan="1">&#x02212;5.0 &#x000b1; 0.6</td><td align="left" rowspan="1" colspan="1">&#x02212;5.5 &#x000b1; 0.6</td><td align="left" rowspan="1" colspan="1">&#x02212;5.5 &#x000b1; 0.6</td><td align="left" rowspan="1" colspan="1">0.35</td><td align="left" rowspan="1" colspan="1">0.54</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>PFDA</bold></td><td align="left" rowspan="1" colspan="1">&#x0003c;0.31</td><td align="left" rowspan="1" colspan="1">0.31&#x02013;0.47</td><td align="left" rowspan="1" colspan="1">&#x0003e;0.47</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Median (IQR)</td><td align="left" rowspan="1" colspan="1">0.24 (0.19&#x02013;0.28)</td><td align="left" rowspan="1" colspan="1">0.37 (0.34&#x02013;0.42)</td><td align="left" rowspan="1" colspan="1">0.61 (0.52&#x02013;0.75)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Model 1 (unadjusted)</td><td align="left" rowspan="1" colspan="1">&#x02212;6.0 &#x000b1; 0.4</td><td align="left" rowspan="1" colspan="1">&#x02212;6.4 &#x000b1; 0.4</td><td align="left" rowspan="1" colspan="1">&#x02212;6.8 &#x000b1; 0.4</td><td align="left" rowspan="1" colspan="1">0.18</td><td align="left" rowspan="1" colspan="1">0.21</td></tr><tr><td align="left" rowspan="1" colspan="1">Model 2</td><td align="left" rowspan="1" colspan="1">&#x02212;5.0 &#x000b1; 0.6</td><td align="left" rowspan="1" colspan="1">&#x02212;5.1 &#x000b1; 0.6</td><td align="left" rowspan="1" colspan="1">&#x02212;5.4 &#x000b1; 0.6</td><td align="left" rowspan="1" colspan="1">0.49</td><td align="left" rowspan="1" colspan="1">0.45</td></tr><tr><td align="left" rowspan="1" colspan="1">Model 3</td><td align="left" rowspan="1" colspan="1">&#x02212;5.2 &#x000b1; 0.6</td><td align="left" rowspan="1" colspan="1">&#x02212;5.3 &#x000b1; 0.6</td><td align="left" rowspan="1" colspan="1">&#x02212;5.5 &#x000b1; 0.6</td><td align="left" rowspan="1" colspan="1">0.56</td><td align="left" rowspan="1" colspan="1">0.76</td></tr><tr><td align="left" colspan="6" rowspan="1"><bold>Weight change (kg) during 6&#x02013;24 months; total <italic>n =</italic> 520</bold></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>PFOS</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Model 1 (unadjusted)</td><td align="left" rowspan="1" colspan="1">1.6 &#x000b1; 0.4</td><td align="left" rowspan="1" colspan="1">3.3 &#x000b1; 0.4</td><td align="left" rowspan="1" colspan="1">3.2 &#x000b1; 0.4</td><td align="left" rowspan="1" colspan="1">0.003</td><td align="left" rowspan="1" colspan="1">0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">Model 2</td><td align="left" rowspan="1" colspan="1">1.8 &#x000b1; 0.6</td><td align="left" rowspan="1" colspan="1">3.4 &#x000b1; 0.6</td><td align="left" rowspan="1" colspan="1">3.3 &#x000b1; 0.6</td><td align="left" rowspan="1" colspan="1">0.009</td><td align="left" rowspan="1" colspan="1">0.03</td></tr><tr><td align="left" rowspan="1" colspan="1">Model 3</td><td align="left" rowspan="1" colspan="1">1.5 &#x000b1; 0.6</td><td align="left" rowspan="1" colspan="1">3.5 &#x000b1; 0.6</td><td align="left" rowspan="1" colspan="1">3.2 &#x000b1; 0.6</td><td align="left" rowspan="1" colspan="1">0.007</td><td align="left" rowspan="1" colspan="1">0.02</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>PFOA</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Model 1 (unadjusted)</td><td align="left" rowspan="1" colspan="1">1.8 &#x000b1; 0.4</td><td align="left" rowspan="1" colspan="1">3.3 &#x000b1; 0.4</td><td align="left" rowspan="1" colspan="1">3.0 &#x000b1; 0.4</td><td align="left" rowspan="1" colspan="1">0.03</td><td align="left" rowspan="1" colspan="1">0.04</td></tr><tr><td align="left" rowspan="1" colspan="1">Model 2</td><td align="left" rowspan="1" colspan="1">2.2 &#x000b1; 0.6</td><td align="left" rowspan="1" colspan="1">3.6 &#x000b1; 0.6</td><td align="left" rowspan="1" colspan="1">3.0 &#x000b1; 0.6</td><td align="left" rowspan="1" colspan="1">0.16</td><td align="left" rowspan="1" colspan="1">0.12</td></tr><tr><td align="left" rowspan="1" colspan="1">Model 3</td><td align="left" rowspan="1" colspan="1">1.8 &#x000b1; 0.6</td><td align="left" rowspan="1" colspan="1">3.6 &#x000b1; 0.6</td><td align="left" rowspan="1" colspan="1">2.9 &#x000b1; 0.6</td><td align="left" rowspan="1" colspan="1">0.07</td><td align="left" rowspan="1" colspan="1">0.06</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>PFHxS</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Model 1 (unadjusted)</td><td align="left" rowspan="1" colspan="1">2.4 &#x000b1; 0.4</td><td align="left" rowspan="1" colspan="1">2.5 &#x000b1; 0.4</td><td align="left" rowspan="1" colspan="1">3.1 &#x000b1; 0.4</td><td align="left" rowspan="1" colspan="1">0.26</td><td align="left" rowspan="1" colspan="1">0.42</td></tr><tr><td align="left" rowspan="1" colspan="1">Model 2</td><td align="left" rowspan="1" colspan="1">2.6 &#x000b1; 0.6</td><td align="left" rowspan="1" colspan="1">2.7 &#x000b1; 0.6</td><td align="left" rowspan="1" colspan="1">3.2 &#x000b1; 0.6</td><td align="left" rowspan="1" colspan="1">0.32</td><td align="left" rowspan="1" colspan="1">0.49</td></tr><tr><td align="left" rowspan="1" colspan="1">Model 3</td><td align="left" rowspan="1" colspan="1">2.4 &#x000b1; 0.6</td><td align="left" rowspan="1" colspan="1">2.7 &#x000b1; 0.6</td><td align="left" rowspan="1" colspan="1">3.3 &#x000b1; 0.7</td><td align="left" rowspan="1" colspan="1">0.18</td><td align="left" rowspan="1" colspan="1">0.21</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>PFNA</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Model 1 (unadjusted)</td><td align="left" rowspan="1" colspan="1">1.7 &#x000b1; 0.4</td><td align="left" rowspan="1" colspan="1">2.9 &#x000b1; 0.4</td><td align="left" rowspan="1" colspan="1">3.5 &#x000b1; 0.4</td><td align="left" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="left" rowspan="1" colspan="1">0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Model 2</td><td align="left" rowspan="1" colspan="1">2.0 &#x000b1; 0.6</td><td align="left" rowspan="1" colspan="1">3.1 &#x000b1; 0.6</td><td align="left" rowspan="1" colspan="1">3.4 &#x000b1; 0.6</td><td align="left" rowspan="1" colspan="1">0.01</td><td align="left" rowspan="1" colspan="1">0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">Model 3</td><td align="left" rowspan="1" colspan="1">1.8 &#x000b1; 0.6</td><td align="left" rowspan="1" colspan="1">3.3 &#x000b1; 0.6</td><td align="left" rowspan="1" colspan="1">3.5 &#x000b1; 0.6</td><td align="left" rowspan="1" colspan="1">0.007</td><td align="left" rowspan="1" colspan="1">0.008</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>PFDA</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Model 1 (unadjusted)</td><td align="left" rowspan="1" colspan="1">2.1 &#x000b1; 0.4</td><td align="left" rowspan="1" colspan="1">2.9 &#x000b1; 0.4</td><td align="left" rowspan="1" colspan="1">3.1 &#x000b1; 0.4</td><td align="left" rowspan="1" colspan="1">0.05</td><td align="left" rowspan="1" colspan="1">0.06</td></tr><tr><td align="left" rowspan="1" colspan="1">Model 2</td><td align="left" rowspan="1" colspan="1">2.3 &#x000b1; 0.6</td><td align="left" rowspan="1" colspan="1">3.0 &#x000b1; 0.6</td><td align="left" rowspan="1" colspan="1">3.1 &#x000b1; 0.6</td><td align="left" rowspan="1" colspan="1">0.16</td><td align="left" rowspan="1" colspan="1">0.14</td></tr><tr><td align="left" rowspan="1" colspan="1">Model 3</td><td align="left" rowspan="1" colspan="1">2.0 &#x000b1; 0.6</td><td align="left" rowspan="1" colspan="1">3.0 &#x000b1; 0.6</td><td align="left" rowspan="1" colspan="1">3.2 &#x000b1; 0.6</td><td align="left" rowspan="1" colspan="1">0.05</td><td align="left" rowspan="1" colspan="1">0.06</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t002fn001"><p>Model 1, unadjusted; Model 2, adjusted for age, sex, race, baseline BMI, education, smoking status, alcohol consumption, physical activity, and dietary intervention group; Model 3, further adjusted for baseline free T3 and free T4 levels.</p></fn><fn id="t002fn002"><p><sup>a</sup>Data are least-square means &#x000b1; standard errors calculated from general linear models.</p></fn><fn id="t002fn003"><p><sup>b</sup>PFAS levels were log<sub>10</sub>-transformed before analysis.</p></fn><fn id="t002fn004"><p>PFAS, perfluoroalkyl substance; PFDA, perfluorodecanoic acid; PFHxS, perfluorohexanesulfonic acid; PFNA, perfluorononanoic acid; PFOA, perfluorooctanoic acid; PFOS, perfluorooctanesulfonic acid; T3, triiodothyronine; T4, thyroxine.</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec020"><title>Sex-specific associations between PFASs and weight regain</title><p>In an analysis stratified by sex, significant associations with weight regain were observed for all individual PFASs in women, but not in men. Comparing the highest to the lowest tertiles, the least-square means (SEs) of weight regain in women were 4.0 (0.8) versus 2.1 (0.9) kg for PFOS (<italic>P</italic><sub>trend</sub> = 0.01); 4.3 (0.9) versus 2.2 (0.8) kg for PFOA (<italic>P</italic><sub>trend</sub> = 0.007); 4.9 (0.9) versus 2.7 (0.8) kg for PFHxS (<italic>P</italic><sub>trend</sub> = 0.009); 4.7 (0.9) versus 2.5 (0.9) kg for PFNA (<italic>P</italic><sub>trend</sub> = 0.006); and 4.2 (0.8) versus 2.5 (0.9) kg for PFDA (<italic>P</italic><sub>trend</sub> = 0.03) (<xref ref-type="table" rid="pmed.1002502.t003">Table 3</xref>). Significant interactions with sex were demonstrated for PFOA and PFHxS (<italic>P</italic><sub>interaction</sub> = 0.04 and 0.01, respectively). When the covariates were entered into the model in a stepwise manner, these results did not change materially (<xref ref-type="supplementary-material" rid="pmed.1002502.s004">S3 Table</xref>). The trajectory of changes in body weight in men and women according to tertiles of PFAS concentrations is shown in <xref ref-type="fig" rid="pmed.1002502.g001">Fig 1</xref>. The trajectory of changes in body weight among total participants is shown in <xref ref-type="supplementary-material" rid="pmed.1002502.s001">S1 Fig</xref>.</p><fig id="pmed.1002502.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pmed.1002502.g001</object-id><label>Fig 1</label><caption><title>Trajectory of changes in body weight in men and women according to tertiles of PFAS concentrations.</title><p>Data are least-square means, adjusted for age, race, education, smoking, alcohol consumption, physical activity, menopausal status (women only), hormone replacement therapy (women only), dietary intervention group, baseline free T3 and free T4 levels, and baseline BMI. PFAS, perfluoroalkyl substance; PFDA, perfluorodecanoic acid; PFHxS, perfluorohexanesulfonic acid; PFNA, perfluorononanoic acid; PFOA, perfluorooctanoic acid; PFOS, perfluorooctanesulfonic acid; T3, triiodothyronine; T4, thyroxine.</p></caption><graphic xlink:href="pmed.1002502.g001"/></fig><table-wrap id="pmed.1002502.t003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pmed.1002502.t003</object-id><label>Table 3</label><caption><title>Sex-stratified analyses of changes in body weight according to baseline plasma PFAS concentrations.</title></caption><alternatives><graphic id="pmed.1002502.t003g" xlink:href="pmed.1002502.t003"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="2" colspan="1">PFAS</th><th align="left" rowspan="2" colspan="1">Sex</th><th align="left" colspan="3" rowspan="1">Tertile of PFAS concentration<xref ref-type="table-fn" rid="t003fn002"><sup>a</sup></xref></th><th align="left" rowspan="2" colspan="1"><italic>P</italic><sub>trend</sub></th><th align="left" rowspan="2" colspan="1"><italic>P</italic><sub>interaction</sub></th></tr><tr><th align="left" rowspan="1" colspan="1">Tertile 1</th><th align="left" rowspan="1" colspan="1">Tertile 2</th><th align="left" rowspan="1" colspan="1">Tertile 3</th></tr></thead><tbody><tr><td align="left" colspan="7" style="background-color:#FFFFFF" rowspan="1"><bold>Weight change (kg) during first 6 months</bold></td></tr><tr><td align="left" rowspan="2" colspan="1"><bold>PFOS</bold></td><td align="left" rowspan="1" colspan="1">Men</td><td align="left" rowspan="1" colspan="1">&#x02212;4.7 &#x000b1; 1.3</td><td align="left" rowspan="1" colspan="1">&#x02212;6.2 &#x000b1; 1.3</td><td align="left" rowspan="1" colspan="1">&#x02212;5.1 &#x000b1; 1.2</td><td align="left" rowspan="1" colspan="1">0.91</td><td align="left" rowspan="2" colspan="1">0.61</td></tr><tr><td align="left" rowspan="1" colspan="1">Women</td><td align="left" rowspan="1" colspan="1">&#x02212;4.7 &#x000b1; 0.7</td><td align="left" rowspan="1" colspan="1">&#x02212;5.2 &#x000b1; 0.7</td><td align="left" rowspan="1" colspan="1">&#x02212;5.1 &#x000b1; 0.7</td><td align="left" rowspan="1" colspan="1">0.49</td></tr><tr><td align="left" rowspan="2" colspan="1"><bold>PFOA</bold></td><td align="left" rowspan="1" colspan="1">Men</td><td align="left" rowspan="1" colspan="1">&#x02212;6.2 &#x000b1; 1.3</td><td align="left" rowspan="1" colspan="1">&#x02212;4.9 &#x000b1; 1.2</td><td align="left" rowspan="1" colspan="1">&#x02212;4.7 &#x000b1; 1.2</td><td align="left" rowspan="1" colspan="1">0.26</td><td align="left" rowspan="2" colspan="1">0.34</td></tr><tr><td align="left" rowspan="1" colspan="1">Women</td><td align="left" rowspan="1" colspan="1">&#x02212;4.7 &#x000b1; 0.7</td><td align="left" rowspan="1" colspan="1">&#x02212;5.5 &#x000b1; 0.7</td><td align="left" rowspan="1" colspan="1">&#x02212;4.9 &#x000b1; 0.7</td><td align="left" rowspan="1" colspan="1">0.65</td></tr><tr><td align="left" rowspan="2" colspan="1"><bold>PFHxS</bold></td><td align="left" rowspan="1" colspan="1">Men</td><td align="left" rowspan="1" colspan="1">&#x02212;5.4 &#x000b1; 1.4</td><td align="left" rowspan="1" colspan="1">&#x02212;5.3 &#x000b1; 1.2</td><td align="left" rowspan="1" colspan="1">&#x02212;4.8 &#x000b1; 1.3</td><td align="left" rowspan="1" colspan="1">0.56</td><td align="left" rowspan="2" colspan="1">0.84</td></tr><tr><td align="left" rowspan="1" colspan="1">Women</td><td align="left" rowspan="1" colspan="1">&#x02212;5.1 &#x000b1; 0.7</td><td align="left" rowspan="1" colspan="1">&#x02212;4.6 &#x000b1; 0.7</td><td align="left" rowspan="1" colspan="1">&#x02212;5.1 &#x000b1; 0.8</td><td align="left" rowspan="1" colspan="1">0.85</td></tr><tr><td align="left" rowspan="2" colspan="1"><bold>PFNA</bold></td><td align="left" rowspan="1" colspan="1">Men</td><td align="left" rowspan="1" colspan="1">&#x02212;5.0 &#x000b1; 1.2</td><td align="left" rowspan="1" colspan="1">&#x02212;6.0 &#x000b1; 1.2</td><td align="left" rowspan="1" colspan="1">&#x02212;4.7 &#x000b1; 1.2</td><td align="left" rowspan="1" colspan="1">0.76</td><td align="left" rowspan="2" colspan="1">0.73</td></tr><tr><td align="left" rowspan="1" colspan="1">Women</td><td align="left" rowspan="1" colspan="1">&#x02212;4.4 &#x000b1; 0.7</td><td align="left" rowspan="1" colspan="1">&#x02212;4.8 &#x000b1; 0.7</td><td align="left" rowspan="1" colspan="1">&#x02212;5.5 &#x000b1; 0.7</td><td align="left" rowspan="1" colspan="1">0.10</td></tr><tr><td align="left" rowspan="2" colspan="1"><bold>PFDA</bold></td><td align="left" rowspan="1" colspan="1">Men</td><td align="left" rowspan="1" colspan="1">&#x02212;5.2 &#x000b1; 1.2</td><td align="left" rowspan="1" colspan="1">&#x02212;5.5 &#x000b1; 1.2</td><td align="left" rowspan="1" colspan="1">&#x02212;4.8 &#x000b1; 1.3</td><td align="left" rowspan="1" colspan="1">0.70</td><td align="left" rowspan="2" colspan="1">0.51</td></tr><tr><td align="left" rowspan="1" colspan="1">Women</td><td align="left" rowspan="1" colspan="1">&#x02212;4.6 &#x000b1; 0.8</td><td align="left" rowspan="1" colspan="1">&#x02212;4.6 &#x000b1; 0.7</td><td align="left" rowspan="1" colspan="1">&#x02212;5.5 &#x000b1; 0.7</td><td align="left" rowspan="1" colspan="1">0.16</td></tr><tr><td align="left" colspan="7" rowspan="1"><bold>Weight change (kg) during 6&#x02013;24 months</bold></td></tr><tr><td align="left" rowspan="2" colspan="1"><bold>PFOS</bold></td><td align="left" rowspan="1" colspan="1">Men</td><td align="left" rowspan="1" colspan="1">1.2 &#x000b1; 1.1</td><td align="left" rowspan="1" colspan="1">3.4 &#x000b1; 1.2</td><td align="left" rowspan="1" colspan="1">2.5 &#x000b1; 1.1</td><td align="left" rowspan="1" colspan="1">0.34</td><td align="left" rowspan="2" colspan="1">0.50</td></tr><tr><td align="left" rowspan="1" colspan="1">Women</td><td align="left" rowspan="1" colspan="1">2.1 &#x000b1; 0.9</td><td align="left" rowspan="1" colspan="1">4.1 &#x000b1; 0.9</td><td align="left" rowspan="1" colspan="1">4.0 &#x000b1; 0.8</td><td align="left" rowspan="1" colspan="1">0.01</td></tr><tr><td align="left" rowspan="2" colspan="1"><bold>PFOA</bold></td><td align="left" rowspan="1" colspan="1">Men</td><td align="left" rowspan="1" colspan="1">1.6 &#x000b1; 1.1</td><td align="left" rowspan="1" colspan="1">3.1 &#x000b1; 1.1</td><td align="left" rowspan="1" colspan="1">1.6 &#x000b1; 1.1</td><td align="left" rowspan="1" colspan="1">0.78</td><td align="left" rowspan="2" colspan="1">0.04</td></tr><tr><td align="left" rowspan="1" colspan="1">Women</td><td align="left" rowspan="1" colspan="1">2.2 &#x000b1; 0.8</td><td align="left" rowspan="1" colspan="1">4.2 &#x000b1; 0.9</td><td align="left" rowspan="1" colspan="1">4.3 &#x000b1; 0.9</td><td align="left" rowspan="1" colspan="1">0.007</td></tr><tr><td align="left" rowspan="2" colspan="1"><bold>PFHxS</bold></td><td align="left" rowspan="1" colspan="1">Men</td><td align="left" rowspan="1" colspan="1">3.5 &#x000b1; 1.2</td><td align="left" rowspan="1" colspan="1">1.5 &#x000b1; 1.1</td><td align="left" rowspan="1" colspan="1">1.4 &#x000b1; 1.1</td><td align="left" rowspan="1" colspan="1">0.17</td><td align="left" rowspan="2" colspan="1">0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">Women</td><td align="left" rowspan="1" colspan="1">2.7 &#x000b1; 0.8</td><td align="left" rowspan="1" colspan="1">3.6 &#x000b1; 0.9</td><td align="left" rowspan="1" colspan="1">4.9 &#x000b1; 0.9</td><td align="left" rowspan="1" colspan="1">0.009</td></tr><tr><td align="left" rowspan="2" colspan="1"><bold>PFNA</bold></td><td align="left" rowspan="1" colspan="1">Men</td><td align="left" rowspan="1" colspan="1">1.4 &#x000b1; 1.1</td><td align="left" rowspan="1" colspan="1">3.4 &#x000b1; 1.1</td><td align="left" rowspan="1" colspan="1">2.2 &#x000b1; 1.1</td><td align="left" rowspan="1" colspan="1">0.48</td><td align="left" rowspan="2" colspan="1">0.31</td></tr><tr><td align="left" rowspan="1" colspan="1">Women</td><td align="left" rowspan="1" colspan="1">2.5 &#x000b1; 0.9</td><td align="left" rowspan="1" colspan="1">2.9 &#x000b1; 0.9</td><td align="left" rowspan="1" colspan="1">4.7 &#x000b1; 0.9</td><td align="left" rowspan="1" colspan="1">0.006</td></tr><tr><td align="left" rowspan="2" colspan="1"><bold>PFDA</bold></td><td align="left" rowspan="1" colspan="1">Men</td><td align="left" rowspan="1" colspan="1">1.6 &#x000b1; 1.1</td><td align="left" rowspan="1" colspan="1">3.2 &#x000b1; 1.1</td><td align="left" rowspan="1" colspan="1">1.8 &#x000b1; 1.2</td><td align="left" rowspan="1" colspan="1">0.75</td><td align="left" rowspan="2" colspan="1">0.33</td></tr><tr><td align="left" rowspan="1" colspan="1">Women</td><td align="left" rowspan="1" colspan="1">2.5 &#x000b1; 0.9</td><td align="left" rowspan="1" colspan="1">3.1 &#x000b1; 0.9</td><td align="left" rowspan="1" colspan="1">4.2 &#x000b1; 0.8</td><td align="left" rowspan="1" colspan="1">0.03</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t003fn001"><p>Data are least-square means &#x000b1; standard errors calculated from general linear models, with adjustment for age, race, baseline BMI, education, smoking status, alcohol consumption, physical activity, dietary intervention group, and baseline free T3 and free T4 levels. Participants included 237 men and 384 women in the first 6 months, and 202 men and 318 women during the period of 6&#x02013;24 months.</p></fn><fn id="t003fn002"><p><sup>a</sup>The cutoffs for each PFAS were the same as those in <xref ref-type="table" rid="pmed.1002502.t002">Table 2</xref>.</p></fn><fn id="t003fn003"><p>PFAS, perfluoroalkyl substance; PFDA, perfluorodecanoic acid; PFHxS, perfluorohexanesulfonic acid; PFNA, perfluorononanoic acid; PFOA, perfluorooctanoic acid; PFOS, perfluorooctanesulfonic acid; T3, triiodothyronine; T4, thyroxine.</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec021"><title>Baseline PFASs and changes in RMR</title><p>After multivariate adjustment, including baseline RMR and dietary intervention group, baseline plasma PFAS concentrations, especially for PFOS and PFNA, were significantly associated with a greater decline in RMR during the weight-loss period (first 6 months) and a lower increase in RMR during the weight regain period (6&#x02013;24 months). During the first 6 months, comparing the highest to the lowest tertiles, the least-square means (SEs) of RMR change were &#x02212;45.4 (15.5) versus &#x02212;5.0 (16.3) kcal/day for PFOS (<italic>P</italic><sub>trend</sub> = 0.005) and &#x02212;49.8 (15.9) versus &#x02212;3.3 (16.1) kcal/day for PFNA (<italic>P</italic><sub>trend</sub> = 0.002) (Model 3 in <xref ref-type="table" rid="pmed.1002502.t004">Table 4</xref>). During the period of 6&#x02013;24 months, comparing the highest to the lowest tertiles, the least-square means (SEs) of RMR change were 0.9 (26.2) versus 94.6 (27.5) kcal/day for PFOS (<italic>P</italic><sub>trend</sub> &#x0003c; 0.001); 12.7 (28.1) versus 69.3 (27.3) kcal/day for PFOA (<italic>P</italic><sub>trend</sub> = 0.03); 24.6 (28.5) versus 81.5 (27.5) kcal/day for PFHxS (<italic>P</italic><sub>trend</sub> = 0.03); 14.1 (27.7) versus 73.7 (27.6) kcal/day for PFNA (<italic>P</italic><sub>trend</sub> = 0.02); and 23.1 (27.6) versus 66.5 (28.2) kcal/day for PFDA (<italic>P</italic><sub>trend</sub> = 0.09) (Model 3 in <xref ref-type="table" rid="pmed.1002502.t004">Table 4</xref>). The results were similar when PFAS concentrations were treated as continuous variables (<xref ref-type="table" rid="pmed.1002502.t004">Table 4</xref>). When adjusting for RMR at 6 months (instead of RMR at baseline), the results maintained statistical significance. When changes in RMR or changes in thyroid hormones during the first 6 months were further adjusted for, the results remained largely unchanged. In the sex-stratified analysis, similar results were observed, although some associations did not reach statistical significance, possibly due to diminished power (<xref ref-type="supplementary-material" rid="pmed.1002502.s005">S4 Table</xref>). No interaction between PFASs and sex on RMR changes was detected. The trajectory of changes in RMR among total participants according to tertiles of PFAS concentrations is shown in <xref ref-type="fig" rid="pmed.1002502.g002">Fig 2</xref>. In addition, similar results were demonstrated when analyses were stratified by dietary intervention group.</p><fig id="pmed.1002502.g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pmed.1002502.g002</object-id><label>Fig 2</label><caption><title>Trajectory of changes in RMR of all participants according to tertiles of PFAS concentrations.</title><p>Data were adjusted for age, sex, race, education, smoking, alcohol consumption, physical activity, menopausal status (women only), hormone replacement therapy (women only), dietary intervention group, baseline free T3 and free T4 levels, and baseline RMR. LS, least-square; PFAS, perfluoroalkyl substance; PFDA, perfluorodecanoic acid; PFHxS, perfluorohexanesulfonic acid; PFNA, perfluorononanoic acid; PFOA, perfluorooctanoic acid; PFOS, perfluorooctanesulfonic acid; RMR, resting metabolic rate; T3, triiodothyronine; T4, thyroxine.</p></caption><graphic xlink:href="pmed.1002502.g002"/></fig><table-wrap id="pmed.1002502.t004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pmed.1002502.t004</object-id><label>Table 4</label><caption><title>Changes in resting metabolic rate (RMR)<xref ref-type="table-fn" rid="t004fn002"><sup>a</sup></xref> according to tertiles of PFAS levels at baseline.</title></caption><alternatives><graphic id="pmed.1002502.t004g" xlink:href="pmed.1002502.t004"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="2" style="background-color:#FFFFFF" colspan="1">PFAS</th><th align="left" colspan="3" style="background-color:#FFFFFF" rowspan="1">Tertile of PFAS concentration</th><th align="left" rowspan="2" style="background-color:#FFFFFF" colspan="1"><italic>P</italic><sub>trend</sub></th><th align="left" rowspan="2" style="background-color:#FFFFFF" colspan="1"><italic>P</italic><sub>continuous</sub><xref ref-type="table-fn" rid="t004fn003"><sup>b</sup></xref></th></tr><tr><th align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">T1</th><th align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">T2</th><th align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">T3</th></tr></thead><tbody><tr><td align="left" colspan="6" style="background-color:#FFFFFF" rowspan="1"><bold>RMR change (kcal/day) during first 6 months; total <italic>n =</italic> 556</bold></td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"><bold>PFOS</bold></td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Model 1 (unadjusted)</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x02212;39.1 &#x000b1; 10.4</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x02212;79.5 &#x000b1; 10.2</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x02212;99.3 &#x000b1; 10.1</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Model 2</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">6.9 &#x000b1; 15.6</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x02212;21.3 &#x000b1; 15.7</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x02212;48.6 &#x000b1; 14.8</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Model 3</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x02212;5.0 &#x000b1; 16.3</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x02212;24.7 &#x000b1; 16.5</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x02212;45.4 &#x000b1; 15.5</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.005</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.02</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"><bold>PFOA</bold></td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Model 1 (unadjusted)</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x02212;58.9 &#x000b1; 10.4</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x02212;67.0 &#x000b1; 10.2</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x02212;93.8 &#x000b1; 10.4</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.02</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.03</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Model 2</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x02212;21.4 &#x000b1; 15.5</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x02212;18.2 &#x000b1; 15.9</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x02212;31.3 &#x000b1; 15.5</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.48</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.37</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Model 3</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x02212;33.8 &#x000b1; 16.2</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x02212;21.7 &#x000b1; 16.4</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x02212;26.2 &#x000b1; 16.2</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.61</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.86</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"><bold>PFHxS</bold></td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Model 1 (unadjusted)</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x02212;47.6 &#x000b1; 10.4</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x02212;67.8 &#x000b1; 10.1</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x02212;103.7 &#x000b1; 10.3</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.005</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Model 2</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x02212;11.9 &#x000b1; 15.4</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x02212;22.4 &#x000b1; 15.5</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x02212;42.3 &#x000b1; 16.0</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.04</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.20</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Model 3</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x02212;23.3 &#x000b1; 16.1</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x02212;21.6 &#x000b1; 15.9</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x02212;41.0 &#x000b1; 16.8</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.25</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.75</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"><bold>PFNA</bold></td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Model 1 (unadjusted)</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x02212;33.3 &#x000b1; 10.3</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x02212;77.0 &#x000b1; 10.0</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x02212;108.2 &#x000b1; 10.2</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Model 2</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">8.1 &#x000b1; 15.3</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x02212;24.3 &#x000b1; 15.4</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x02212;54.6 &#x000b1; 15.1</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Model 3</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x02212;3.3 &#x000b1; 16.1</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x02212;27.5 &#x000b1; 16.2</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x02212;49.8 &#x000b1; 15.9</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.002</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.003</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"><bold>PFDA</bold></td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Model 1 (unadjusted)</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x02212;64.2 &#x000b1; 10.5</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x02212;60.4 &#x000b1; 10.2</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x02212;95.2 &#x000b1; 10.4</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.03</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.01</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Model 2</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x02212;8.8 &#x000b1; 15.7</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x02212;15.7 &#x000b1; 15.5</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x02212;43.1 &#x000b1; 15.2</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.01</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.002</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Model 3</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x02212;17.5 &#x000b1; 16.6</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x02212;19.4 &#x000b1; 15.9</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x02212;42.1 &#x000b1; 15.8</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.09</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.05</td></tr><tr><td align="left" colspan="6" style="background-color:#FFFFFF" rowspan="1"><bold>RMR change (kcal/day) during 6&#x02013;24 months; total <italic>n =</italic> 393</bold></td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"><bold>PFOS</bold></td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Model 1 (unadjusted)</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">102.6 &#x000b1; 16.5</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">82.5 &#x000b1; 16.3</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">16.9 &#x000b1; 16.6</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Model 2</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">108.3 &#x000b1; 27.4</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">83.3 &#x000b1; 28.1</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">17.2 &#x000b1; 26.0</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Model 3</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">94.6 &#x000b1; 27.5</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">67.3 &#x000b1; 28.3</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.9 &#x000b1; 26.2</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.001</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"><bold>PFOA</bold></td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Model 1 (unadjusted)</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">86.8 &#x000b1; 16.7</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">80.5 &#x000b1; 16.2</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">33.3 &#x000b1; 17.1</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.03</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.02</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Model 2</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">82.4 &#x000b1; 26.9</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">73.9 &#x000b1; 27.9</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">27.7 &#x000b1; 27.8</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.03</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.03</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Model 3</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">69.3 &#x000b1; 27.3</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">54.9 &#x000b1; 27.7</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">12.7 &#x000b1; 28.1</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.03</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.04</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"><bold>PFHxS</bold></td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Model 1 (unadjusted)</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">108.7 &#x000b1; 16.7</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">47.6 &#x000b1; 16.4</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">47.7 &#x000b1; 16.6</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.01</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.01</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Model 2</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">100.3 &#x000b1; 27.1</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">37.8 &#x000b1; 27.2</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">39.1 &#x000b1; 28.3</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.02</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.02</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Model 3</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">81.5 &#x000b1; 27.5</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">27.9 &#x000b1; 27.1</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">24.6 &#x000b1; 28.5</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.03</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.04</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"><bold>PFNA</bold></td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Model 1 (unadjusted)</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">88.6 &#x000b1; 16.9</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">78.3 &#x000b1; 15.8</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">33.0 &#x000b1; 17.3</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.02</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.003</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Model 2</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">83.8 &#x000b1; 27.5</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">76.7 &#x000b1; 27.3</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">27.9 &#x000b1; 27.4</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.03</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.004</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Model 3</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">73.7 &#x000b1; 27.6</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">53.3 &#x000b1; 27.6</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">14.1 &#x000b1; 27.7</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.02</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.002</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"><bold>PFDA</bold></td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Model 1 (unadjusted)</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">91.5 &#x000b1; 16.4</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">63.5 &#x000b1; 16.3</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">45.7 &#x000b1; 17.4</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.05</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.06</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Model 2</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">88.6 &#x000b1; 27.7</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">61.8 &#x000b1; 27.4</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">40.3 &#x000b1; 27.2</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.05</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.07</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Model 3</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">66.5 &#x000b1; 28.2</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">55.0 &#x000b1; 27.2</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">23.1 &#x000b1; 27.6</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.09</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.08</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t004fn001"><p>Model 1, unadjusted; Model 2, adjusted for age, sex, race, baseline RMR, education, smoking status, alcohol consumption, physical activity, and dietary intervention group; Model 3, further adjusted for baseline free T3 and free T4 levels.</p></fn><fn id="t004fn002"><p><sup>a</sup>Data are least-square means &#x000b1; standard errors calculated from general linear models.</p></fn><fn id="t004fn003"><p><sup>b</sup>PFAS levels were log<sub>10</sub>-transformed before analysis.</p></fn><fn id="t004fn004"><p>PFAS, perfluoroalkyl substance; PFDA, perfluorodecanoic acid; PFHxS, perfluorohexanesulfonic acid; PFNA, perfluorononanoic acid; PFOA, perfluorooctanoic acid; PFOS, perfluorooctanesulfonic acid; RMR, resting metabolic rate; T3, triiodothyronine; T4, thyroxine.</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec022"><title>Baseline PFASs and changes in other metabolic parameters</title><p>During the weight-loss period, after multivariate adjustment including baseline levels of each metabolic parameter, plasma concentrations of PFOS, PFNA, and PFDA were inversely associated with changes in visceral fat mass (<italic>r</italic><sub>s</sub> ranged from &#x02212;0.19 to &#x02212;0.27, all <italic>P &#x0003c;</italic> 0.05), and baseline PFOA was inversely associated with changes in HDL cholesterol (<italic>r</italic><sub>s</sub> = &#x02212;0.12, <italic>P &#x0003c;</italic> 0.01) (<xref ref-type="supplementary-material" rid="pmed.1002502.s006">S5 Table</xref>). During the weight regain period, baseline PFOS, PFNA, and PFDA levels were positively associated with changes in some of the parameters, including waist circumference, insulin, and leptin (<italic>r</italic><sub>s</sub> ranged from 0.10 to 0.15, all <italic>P &#x0003c;</italic> 0.05), and baseline PFOA and PFHxS were associated with a greater increase in visceral fat mass (<italic>r</italic><sub>s</sub> = 0.30 and 0.27, respectively; both <italic>P &#x0003c;</italic> 0.05) (<xref ref-type="supplementary-material" rid="pmed.1002502.s006">S5 Table</xref>). The results were largely similar when analyses were stratified by sex. In sensitivity analyses, the results did not materially change when further adjusting for study location (Boston or Baton Rouge) or participant compliance (number of sessions participants attended). The table in <xref ref-type="supplementary-material" rid="pmed.1002502.s007">S1 Text</xref> shows the associations of baseline PFASs with gene expression in adipose tissue.</p></sec></sec><sec sec-type="conclusions" id="sec023"><title>Discussion</title><p>In this 2-year randomized weight-loss trial, we found that higher baseline plasma PFAS concentrations were not associated with weight loss induced by energy restriction, but were significantly associated with a greater weight regain, primarily among women, during the follow-up period between 6 and 24 months. In addition, after multivariate adjustment, higher baseline PFAS levels were significantly associated with a greater decrease in RMR during the weight-loss period and a lower increase in RMR during the weight regain period.</p><sec id="sec024"><title>Comparison with other studies</title><p>To date, evidence on the influence of PFAS exposure on body weight change and metabolic parameters has been limited and has been primarily generated from cross-sectional studies that could not establish causal relationships [<xref rid="pmed.1002502.ref030" ref-type="bibr">30</xref>,<xref rid="pmed.1002502.ref044" ref-type="bibr">44</xref>&#x02013;<xref rid="pmed.1002502.ref047" ref-type="bibr">47</xref>]. In addition, the causes of weight change are likely heterogeneous (including diet, physical activity, and medications) and often not well understood in observational studies. Prospective evidence linking PFAS exposure with body weight regulation was primarily from studies that examined prenatal or early life exposures to PFASs in relation to body weight later in life, and the results were somewhat mixed [<xref rid="pmed.1002502.ref021" ref-type="bibr">21</xref>&#x02013;<xref rid="pmed.1002502.ref027" ref-type="bibr">27</xref>,<xref rid="pmed.1002502.ref048" ref-type="bibr">48</xref>,<xref rid="pmed.1002502.ref049" ref-type="bibr">49</xref>]. For example, in 3 birth cohort studies conducted in European populations, maternal concentrations of PFASs were significantly associated with offspring body weight and other anthropometric and metabolic traits, primarily among girls [<xref rid="pmed.1002502.ref021" ref-type="bibr">21</xref>,<xref rid="pmed.1002502.ref023" ref-type="bibr">23</xref>,<xref rid="pmed.1002502.ref025" ref-type="bibr">25</xref>]. However, other studies generated inconsistent findings regarding maternal PFAS exposure and offspring BMI or obesity risk, with no sex difference [<xref rid="pmed.1002502.ref022" ref-type="bibr">22</xref>,<xref rid="pmed.1002502.ref024" ref-type="bibr">24</xref>,<xref rid="pmed.1002502.ref049" ref-type="bibr">49</xref>]. In addition, recently, in the European Youth Heart Study, Domazet et al. demonstrated that higher plasma PFOS concentrations during childhood, but not adolescence, were associated with greater adiposity in adolescence and young adulthood [<xref rid="pmed.1002502.ref048" ref-type="bibr">48</xref>].</p><p>To our knowledge, the current investigation is among the first studies in adults to evaluate the associations of PFAS exposures with changes in body weight and metabolic parameters induced during a controlled weight-loss trial. All individual PFASs were significantly associated with more weight regain in women, but not in men, which was in agreement with previous studies in which the intergenerational effects of PFASs on body weight were observed only in girls and not in boys [<xref rid="pmed.1002502.ref021" ref-type="bibr">21</xref>,<xref rid="pmed.1002502.ref025" ref-type="bibr">25</xref>,<xref rid="pmed.1002502.ref026" ref-type="bibr">26</xref>]. Although the reasons for these gender-specific findings are still unclear, accumulating evidence from experimental research suggests that PFASs are able to interfere with estrogen metabolism and functionalities [<xref rid="pmed.1002502.ref012" ref-type="bibr">12</xref>,<xref rid="pmed.1002502.ref050" ref-type="bibr">50</xref>,<xref rid="pmed.1002502.ref051" ref-type="bibr">51</xref>]. As potential endocrine disruptors, PFASs might reduce estradiol production and the expression of some key genes related to estrogen synthesis [<xref rid="pmed.1002502.ref012" ref-type="bibr">12</xref>], or influence estradiol concentrations through pathways such as hepatic aromatase induction, with an initial inhibition and a later stimulation [<xref rid="pmed.1002502.ref050" ref-type="bibr">50</xref>]. Using in vitro and in silico species comparison approaches, Benninghoff et al. reported that PFASs may interact directly with estrogen receptors, suggesting that PFASs could act as weak environmental xenoestrogens [<xref rid="pmed.1002502.ref051" ref-type="bibr">51</xref>]. The experimental evidence implies that the detrimental effects of PFASs can be sex-specific, thus supporting the notion that women may be particularly vulnerable to obesogenic effects of PFASs. In addition, it is worth noticing that women generally have a higher percentage of body fat than men [<xref rid="pmed.1002502.ref052" ref-type="bibr">52</xref>]. Given that fat-free mass could substantially influence RMR, the difference in body composition between men and women could result in significant differences in energy homeostasis dynamics [<xref rid="pmed.1002502.ref052" ref-type="bibr">52</xref>].</p><p>In addition to the adverse effects of PFASs on estrogen-related pathways, animal studies suggest that PFOA and PFOS may also interfere with energy homeostasis and the endocrine system through other mechanisms [<xref rid="pmed.1002502.ref014" ref-type="bibr">14</xref>,<xref rid="pmed.1002502.ref015" ref-type="bibr">15</xref>,<xref rid="pmed.1002502.ref018" ref-type="bibr">18</xref>,<xref rid="pmed.1002502.ref053" ref-type="bibr">53</xref>], including the activation of PPAR&#x003b1; and PPAR&#x003b3; [<xref rid="pmed.1002502.ref018" ref-type="bibr">18</xref>,<xref rid="pmed.1002502.ref019" ref-type="bibr">19</xref>], key regulators in fatty acid oxidation, differentiation and normal function of adipocytes, and glucose metabolism [<xref rid="pmed.1002502.ref020" ref-type="bibr">20</xref>,<xref rid="pmed.1002502.ref054" ref-type="bibr">54</xref>]. An experiment on human liver cells suggested that PFOA could alter the expression of proteins regulated by hepatocyte nuclear factor 4&#x003b1; [<xref rid="pmed.1002502.ref055" ref-type="bibr">55</xref>], which is a key regulator of lipid metabolism and gluconeogenesis [<xref rid="pmed.1002502.ref056" ref-type="bibr">56</xref>]. In addition, some animal studies have suggested that PFAS exposure might disrupt thyroid hormone homeostasis, possibly via influencing uridine diphosphoglucuronosyl transferases and type 1 deiodinase [<xref rid="pmed.1002502.ref017" ref-type="bibr">17</xref>,<xref rid="pmed.1002502.ref057" ref-type="bibr">57</xref>]. Of note, due to the species-specific toxicokinetics (e.g., the elimination half-lives are 3&#x02013;8 years in humans and 17&#x02013;30 days in mice and monkeys) and tissue distribution of PFASs [<xref rid="pmed.1002502.ref018" ref-type="bibr">18</xref>], caution is needed when extrapolating findings from animal studies to humans. In addition, mechanisms need to be elucidated to interpret the findings that higher baseline PFASs, especially PFOS and PFNA, were associated with changes in RMR, which is a major determinant of weight maintenance, in both men and women [<xref rid="pmed.1002502.ref058" ref-type="bibr">58</xref>,<xref rid="pmed.1002502.ref059" ref-type="bibr">59</xref>]. Finally, whether the 5 major PFASs might have different biological mechanisms and perhaps exert additive or synergistic effects also warrants further exploration.</p></sec><sec id="sec025"><title>Strengths and limitations of study</title><p>The primary strength of the current study is that the cause of weight changes was well characterized. Unlike previous observational studies in which reasons for weight changes were usually unknown, this weight-loss trial applied energy restriction to induce the weight changes. Moreover, repeated measurements of body weight, RMR, thyroid hormones, leptin, and other metabolic biomarkers allowed documentation of longitudinal associations between PFAS exposures and changes in these parameters during the weight-loss and weight regain periods.</p><p>Several limitations should be considered as well. First, although we included men and women with a wide range of ages (30&#x02013;70 years), participants in the current study were otherwise relatively homogeneous in terms of health status and body fatness because they were selected following narrow inclusion criteria. Therefore, it is unclear whether our findings can be extrapolated to more general populations. Second, we measured only the baseline plasma PFAS concentrations. However, given the long elimination half-lives (3&#x02013;8 years) of these chemicals [<xref rid="pmed.1002502.ref036" ref-type="bibr">36</xref>] and a strong stability over time observed in our pilot study, concentrations in the blood likely reflect relatively long-term PFAS exposures. Moreover, unlike many other persistent organic pollutants, PFASs are not lipophilic, and blood concentrations are therefore not affected by changes in the size of the lipid compartment [<xref rid="pmed.1002502.ref060" ref-type="bibr">60</xref>]. Third, we did not measure ghrelin, an orexigenic hormone regulating appetite, RMR, and other key physiological processes related to weight changes [<xref rid="pmed.1002502.ref061" ref-type="bibr">61</xref>], and the interrelationship between PFASs and ghrelin during weight changes needs to be elucidated. Fourth, we did not apply Bonferroni correction in the analyses given the inter-correlation between the PFASs (<italic>r</italic><sub>s</sub> ranged from 0.4 to 0.9), and the role of multiple testing could not be entirely excluded. Fifth, physical activity was assessed using the Baecke questionnaire, which might be subject to measurement errors, although a validation study conducted in US adults has shown reasonable validity of this questionnaire [<xref rid="pmed.1002502.ref062" ref-type="bibr">62</xref>]. In addition, although some covariates including education, smoking status, and physical activity were adjusted for in our study, we could not entirely exclude the possibility that unmeasured or residual confounding by socioeconomic and psychosocial factors, as well as participants&#x02019; usual diet, might partially account for the associations we observed. One particular concern is that PFASs are extensively used in food packaging due to their oil- and water-repellant characteristics [<xref rid="pmed.1002502.ref032" ref-type="bibr">32</xref>]. If some participants relapsed to their usual pre-randomization diet and this diet was rich in foods that are contaminated by PFASs through food packaging and are also dense in energy, they might thus have gained weight faster. However, when we further controlled for the frequency of craving hamburgers, French fries, or donuts at baseline assessed using a questionnaire, the results were largely unchanged. In addition, humans are exposed to PFASs through multiple pathways, including drinking water and contaminated seafood [<xref rid="pmed.1002502.ref031" ref-type="bibr">31</xref>], although these factors are not established risk factors for weight gain. Moreover, we adjusted for the number of study sessions that participants attended, which is a measurement of compliance to the prescribed diet. Finally, lipophilic persistent pollutants with obesogenic effects (such as hexachlorobenzene [HCB] and dichlorodiphenyldichloroethylene [DDE]) might have confounded the associations of PFASs with changes in body weight and RMR. However, in 793 women participating in the Nurses&#x02019; Health Study II, weak associations were observed between PFASs and lipophilic persistent pollutants (e.g., the <italic>r</italic><sub>s</sub> of PFOA and PFOS with HCB was 0.07 and 0.06, respectively, and the <italic>r</italic><sub>s</sub> of PFOA and PFOS with DDE was 0.05 and 0.06, respectively), suggesting that confounding by these pollutants would not be substantial.</p></sec><sec id="sec026"><title>Implications of findings</title><p>Our study provides the first piece of evidence from a controlled weight-loss trial that higher baseline plasma PFAS concentrations in adults are associated with a greater weight regain, especially in women, possibly due to suppressed RMR levels. These findings imply that overweight and obese individuals with relatively low PFAS exposures might potentially benefit more from weight-loss interventions. Although the production of PFOS and PFOA in the US has largely been phased out [<xref rid="pmed.1002502.ref031" ref-type="bibr">31</xref>,<xref rid="pmed.1002502.ref063" ref-type="bibr">63</xref>], the production of other PFASs, such as PFNA, may continue or even increase, especially in developing countries [<xref rid="pmed.1002502.ref064" ref-type="bibr">64</xref>]. Given the persistence of these PFASs in the environment and the human body, their potential adverse effects remain a public health concern.</p></sec><sec id="sec027"><title>Conclusions</title><p>In a diet-induced weight-loss setting among overweight and obese individuals, higher baseline plasma PFAS concentrations were significantly associated with greater weight regain, especially in women, accompanied by a slower regression of RMR. These findings suggest that environmental chemicals may play a role in the current obesity epidemic. More studies are warranted to elucidate the mechanisms underlying the link between PFAS exposure and weight regulation in humans.</p></sec></sec><sec sec-type="supplementary-material" id="sec028"><title>Supporting information</title><supplementary-material content-type="local-data" id="pmed.1002502.s001"><label>S1 Fig</label><caption><title>Trajectory of changes in body weight of all participants according to tertiles of PFAS concentrations.</title><p>Data are least-square means, adjusted for age, sex, race, education, smoking, alcohol consumption, physical activity, menopausal status (women only), hormone replacement therapy (women only), dietary intervention group, baseline free T3 and free T4 levels, and baseline body weight.</p><p>(TIF)</p></caption><media xlink:href="pmed.1002502.s001.tif"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pmed.1002502.s002"><label>S1 Table</label><caption><title>Comparisons of characteristics between included and excluded participants.</title><p>(DOCX)</p></caption><media xlink:href="pmed.1002502.s002.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pmed.1002502.s003"><label>S2 Table</label><caption><title>Partial Spearman correlation coefficients between baseline PFAS concentrations and baseline metabolic parameters.</title><p>(DOCX)</p></caption><media xlink:href="pmed.1002502.s003.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pmed.1002502.s004"><label>S3 Table</label><caption><title>Changes in body weight (6&#x02013;24 months) according to baseline plasma PFAS concentrations among women (<italic>n =</italic> 318).</title><p>(DOCX)</p></caption><media xlink:href="pmed.1002502.s004.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pmed.1002502.s005"><label>S4 Table</label><caption><title>Sex-stratified analyses of changes in RMR according to baseline PFAS concentrations.</title><p>(DOCX)</p></caption><media xlink:href="pmed.1002502.s005.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pmed.1002502.s006"><label>S5 Table</label><caption><title>Partial Spearman correlation coefficients between baseline PFAS concentrations and changes in other metabolic parameters.</title><p>(DOCX)</p></caption><media xlink:href="pmed.1002502.s006.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pmed.1002502.s007"><label>S1 Text</label><caption><title>Gene expression profiling of adipose tissue.</title><p>(DOCX)</p></caption><media xlink:href="pmed.1002502.s007.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pmed.1002502.s008"><label>S2 Text</label><caption><title>STROBE checklist.</title><p>(DOCX)</p></caption><media xlink:href="pmed.1002502.s008.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pmed.1002502.s009"><label>S3 Text</label><caption><title>Study protocol and analysis plan.</title><p>(PDF)</p></caption><media xlink:href="pmed.1002502.s009.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>We thank the participants in the POUNDS Lost trial for their dedication and contribution to the scientific research.</p></ack><glossary><title>Abbreviations</title><def-list><def-item><term>BMI</term><def><p>body mass index</p></def></def-item><def-item><term>HDL</term><def><p>high-density lipoprotein</p></def></def-item><def-item><term>HOMA-IR</term><def><p>homeostatic model assessment of insulin resistance</p></def></def-item><def-item><term>LDL</term><def><p>low-density lipoprotein</p></def></def-item><def-item><term>PFAS</term><def><p>perfluoroalkyl substance</p></def></def-item><def-item><term>PFDA</term><def><p>perfluorodecanoic acid</p></def></def-item><def-item><term>PFHxS</term><def><p>perfluorohexanesulfonic acid</p></def></def-item><def-item><term>PFNA</term><def><p>perfluorononanoic acid</p></def></def-item><def-item><term>PFOA</term><def><p>perfluorooctanoic acid</p></def></def-item><def-item><term>PFOS</term><def><p>perfluorooctanesulfonic acid</p></def></def-item><def-item><term>PPAR</term><def><p>peroxisome proliferator-activated receptor</p></def></def-item><def-item><term>RMR</term><def><p>resting metabolic rate</p></def></def-item><def-item><term>T3</term><def><p>triiodothyronine</p></def></def-item><def-item><term>T4</term><def><p>thyroxine</p></def></def-item></def-list></glossary><ref-list><title>References</title><ref id="pmed.1002502.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>Y</given-names></name>, <name><surname>Beydoun</surname><given-names>MA</given-names></name>, <name><surname>Liang</surname><given-names>L</given-names></name>, <name><surname>Caballero</surname><given-names>B</given-names></name>, <name><surname>Kumanyika</surname><given-names>SK</given-names></name>. <article-title>Will all Americans become overweight or obese? Estimating the progression and cost of the US obesity epidemic</article-title>. <source>Obesity (Silver Spring)</source>. <year>2008</year>;<volume>16</volume>:<fpage>2323</fpage>&#x02013;<lpage>30</lpage>.<pub-id pub-id-type="pmid">18719634</pub-id></mixed-citation></ref><ref id="pmed.1002502.ref002"><label>2</label><mixed-citation publication-type="journal"><collab>GBD 2015 Obesity Collaborators</collab>, <name><surname>Afshin</surname><given-names>A</given-names></name>, <name><surname>Forouzanfar</surname><given-names>MH</given-names></name>, <name><surname>Reitsma</surname><given-names>MB</given-names></name>, <name><surname>Sur</surname><given-names>P</given-names></name>, <name><surname>Estep</surname><given-names>K</given-names></name>, <etal>et al</etal>
<article-title>Health effects of overweight and obesity in 195 countries over 25 years</article-title>. <source>N Engl J Med</source>. <year>2017</year>;<volume>377</volume>:<fpage>13</fpage>&#x02013;<lpage>27</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1056/NEJMoa1614362">10.1056/NEJMoa1614362</ext-link></comment>
<pub-id pub-id-type="pmid">28604169</pub-id></mixed-citation></ref><ref id="pmed.1002502.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>Flegal</surname><given-names>KM</given-names></name>, <name><surname>Kruszon-Moran</surname><given-names>D</given-names></name>, <name><surname>Carroll</surname><given-names>MD</given-names></name>, <name><surname>Fryar</surname><given-names>CD</given-names></name>, <name><surname>Ogden</surname><given-names>CL</given-names></name>. <article-title>Trends in obesity among adults in the United States, 2005 to 2014</article-title>. <source>JAMA</source>. <year>2016</year>;<volume>315</volume>:<fpage>2284</fpage>&#x02013;<lpage>91</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1001/jama.2016.6458">10.1001/jama.2016.6458</ext-link></comment>
<pub-id pub-id-type="pmid">27272580</pub-id></mixed-citation></ref><ref id="pmed.1002502.ref004"><label>4</label><mixed-citation publication-type="journal"><name><surname>Seidell</surname><given-names>JC</given-names></name>, <name><surname>Halberstadt</surname><given-names>J</given-names></name>. <article-title>Obesity: the obesity epidemic in the USA&#x02014;no end in sight?</article-title>
<source>Nat Rev Endocrinol</source>. <year>2016</year>;<volume>12</volume>:<fpage>499</fpage>&#x02013;<lpage>500</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nrendo.2016.121">10.1038/nrendo.2016.121</ext-link></comment>
<pub-id pub-id-type="pmid">27469344</pub-id></mixed-citation></ref><ref id="pmed.1002502.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Ogden</surname><given-names>CL</given-names></name>, <name><surname>Carroll</surname><given-names>MD</given-names></name>, <name><surname>Lawman</surname><given-names>HG</given-names></name>, <name><surname>Fryar</surname><given-names>CD</given-names></name>, <name><surname>Kruszon-Moran</surname><given-names>D</given-names></name>, <name><surname>Kit</surname><given-names>BK</given-names></name>, <etal>et al</etal>
<article-title>Trends in obesity prevalence among children and adolescents in the United States, 1988&#x02013;1994 through 2013&#x02013;2014</article-title>. <source>JAMA</source>. <year>2016</year>;<volume>315</volume>:<fpage>2292</fpage>&#x02013;<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1001/jama.2016.6361">10.1001/jama.2016.6361</ext-link></comment>
<pub-id pub-id-type="pmid">27272581</pub-id></mixed-citation></ref><ref id="pmed.1002502.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>Svetkey</surname><given-names>LP</given-names></name>, <name><surname>Stevens</surname><given-names>VJ</given-names></name>, <name><surname>Brantley</surname><given-names>PJ</given-names></name>, <name><surname>Appel</surname><given-names>LJ</given-names></name>, <name><surname>Hollis</surname><given-names>JF</given-names></name>, <name><surname>Loria</surname><given-names>CM</given-names></name>, <etal>et al</etal>
<article-title>Comparison of strategies for sustaining weight loss: the weight loss maintenance randomized controlled trial</article-title>. <source>JAMA</source>. <year>2008</year>;<volume>299</volume>:<fpage>1139</fpage>&#x02013;<lpage>48</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1001/jama.299.10.1139">10.1001/jama.299.10.1139</ext-link></comment>
<pub-id pub-id-type="pmid">18334689</pub-id></mixed-citation></ref><ref id="pmed.1002502.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>Elfhag</surname><given-names>K</given-names></name>, <name><surname>Rossner</surname><given-names>S</given-names></name>. <article-title>Who succeeds in maintaining weight loss? A conceptual review of factors associated with weight loss maintenance and weight regain</article-title>. <source>Obes Rev</source>. <year>2005</year>;<volume>6</volume>:<fpage>67</fpage>&#x02013;<lpage>85</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1467-789X.2005.00170.x">10.1111/j.1467-789X.2005.00170.x</ext-link></comment>
<pub-id pub-id-type="pmid">15655039</pub-id></mixed-citation></ref><ref id="pmed.1002502.ref008"><label>8</label><mixed-citation publication-type="journal"><name><surname>King</surname><given-names>NA</given-names></name>, <name><surname>Hopkins</surname><given-names>M</given-names></name>, <name><surname>Caudwell</surname><given-names>P</given-names></name>, <name><surname>Stubbs</surname><given-names>RJ</given-names></name>, <name><surname>Blundell</surname><given-names>JE</given-names></name>. <article-title>Individual variability following 12 weeks of supervised exercise: identification and characterization of compensation for exercise-induced weight loss</article-title>. <source>Int J Obes (Lond)</source>. <year>2008</year>;<volume>32</volume>:<fpage>177</fpage>&#x02013;<lpage>84</lpage>.<pub-id pub-id-type="pmid">17848941</pub-id></mixed-citation></ref><ref id="pmed.1002502.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Holtcamp</surname><given-names>W</given-names></name>. <article-title>Obesogens: an environmental link to obesity</article-title>. <source>Environ Health Perspect</source>. <year>2012</year>;<volume>120</volume>:<fpage>a62</fpage>&#x02013;<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1289/ehp.120-a62">10.1289/ehp.120-a62</ext-link></comment>
<pub-id pub-id-type="pmid">22296745</pub-id></mixed-citation></ref><ref id="pmed.1002502.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>Grun</surname><given-names>F</given-names></name>. <article-title>Obesogens</article-title>. <source>Curr Opin Endocrinol Diabetes Obes</source>. <year>2010</year>;<volume>17</volume>:<fpage>453</fpage>&#x02013;<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1097/MED.0b013e32833ddea0">10.1097/MED.0b013e32833ddea0</ext-link></comment>
<pub-id pub-id-type="pmid">20689419</pub-id></mixed-citation></ref><ref id="pmed.1002502.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>Grun</surname><given-names>F</given-names></name>, <name><surname>Blumberg</surname><given-names>B</given-names></name>. <article-title>Endocrine disrupters as obesogens</article-title>. <source>Mol Cell Endocrinol</source>. <year>2009</year>;<volume>304</volume>:<fpage>19</fpage>&#x02013;<lpage>29</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.mce.2009.02.018">10.1016/j.mce.2009.02.018</ext-link></comment>
<pub-id pub-id-type="pmid">19433244</pub-id></mixed-citation></ref><ref id="pmed.1002502.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Shi</surname><given-names>Z</given-names></name>, <name><surname>Zhang</surname><given-names>H</given-names></name>, <name><surname>Ding</surname><given-names>L</given-names></name>, <name><surname>Feng</surname><given-names>Y</given-names></name>, <name><surname>Xu</surname><given-names>M</given-names></name>, <name><surname>Dai</surname><given-names>J</given-names></name>. <article-title>The effect of perfluorododecanonic acid on endocrine status, sex hormones and expression of steroidogenic genes in pubertal female rats</article-title>. <source>Reprod Toxicol</source>. <year>2009</year>;<volume>27</volume>:<fpage>352</fpage>&#x02013;<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.reprotox.2009.02.008">10.1016/j.reprotox.2009.02.008</ext-link></comment>
<pub-id pub-id-type="pmid">19429406</pub-id></mixed-citation></ref><ref id="pmed.1002502.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Du</surname><given-names>G</given-names></name>, <name><surname>Huang</surname><given-names>H</given-names></name>, <name><surname>Hu</surname><given-names>J</given-names></name>, <name><surname>Qin</surname><given-names>Y</given-names></name>, <name><surname>Wu</surname><given-names>D</given-names></name>, <name><surname>Song</surname><given-names>L</given-names></name>, <etal>et al</etal>
<article-title>Endocrine-related effects of perfluorooctanoic acid (PFOA) in zebrafish, H295R steroidogenesis and receptor reporter gene assays</article-title>. <source>Chemosphere</source>. <year>2013</year>;<volume>91</volume>:<fpage>1099</fpage>&#x02013;<lpage>106</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.chemosphere.2013.01.012">10.1016/j.chemosphere.2013.01.012</ext-link></comment>
<pub-id pub-id-type="pmid">23399300</pub-id></mixed-citation></ref><ref id="pmed.1002502.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>White</surname><given-names>SS</given-names></name>, <name><surname>Fenton</surname><given-names>SE</given-names></name>, <name><surname>Hines</surname><given-names>EP</given-names></name>. <article-title>Endocrine disrupting properties of perfluorooctanoic acid</article-title>. <source>J Steroid Biochem Mol Biol</source>. <year>2011</year>;<volume>127</volume>:<fpage>16</fpage>&#x02013;<lpage>26</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jsbmb.2011.03.011">10.1016/j.jsbmb.2011.03.011</ext-link></comment>
<pub-id pub-id-type="pmid">21397692</pub-id></mixed-citation></ref><ref id="pmed.1002502.ref015"><label>15</label><mixed-citation publication-type="journal"><name><surname>Kirkley</surname><given-names>AG</given-names></name>, <name><surname>Sargis</surname><given-names>RM</given-names></name>. <article-title>Environmental endocrine disruption of energy metabolism and cardiovascular risk</article-title>. <source>Curr Diab Rep</source>. <year>2014</year>;<volume>14</volume>:<fpage>494</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s11892-014-0494-0">10.1007/s11892-014-0494-0</ext-link></comment>
<pub-id pub-id-type="pmid">24756343</pub-id></mixed-citation></ref><ref id="pmed.1002502.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>Chang</surname><given-names>SC</given-names></name>, <name><surname>Thibodeaux</surname><given-names>JR</given-names></name>, <name><surname>Eastvold</surname><given-names>ML</given-names></name>, <name><surname>Ehresman</surname><given-names>DJ</given-names></name>, <name><surname>Bjork</surname><given-names>JA</given-names></name>, <name><surname>Froehlich</surname><given-names>JW</given-names></name>, <etal>et al</etal>
<article-title>Thyroid hormone status and pituitary function in adult rats given oral doses of perfluorooctanesulfonate (PFOS)</article-title>. <source>Toxicology</source>. <year>2008</year>;<volume>243</volume>:<fpage>330</fpage>&#x02013;<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.tox.2007.10.014">10.1016/j.tox.2007.10.014</ext-link></comment>
<pub-id pub-id-type="pmid">18063289</pub-id></mixed-citation></ref><ref id="pmed.1002502.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>Yu</surname><given-names>WG</given-names></name>, <name><surname>Liu</surname><given-names>W</given-names></name>, <name><surname>Jin</surname><given-names>YH</given-names></name>. <article-title>Effects of perfluorooctane sulfonate on rat thyroid hormone biosynthesis and metabolism</article-title>. <source>Environ Toxicol Chem</source>. <year>2009</year>;<volume>28</volume>:<fpage>990</fpage>&#x02013;<lpage>6</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1897/08-345.1">10.1897/08-345.1</ext-link></comment>
<pub-id pub-id-type="pmid">19045937</pub-id></mixed-citation></ref><ref id="pmed.1002502.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Lau</surname><given-names>C</given-names></name>, <name><surname>Anitole</surname><given-names>K</given-names></name>, <name><surname>Hodes</surname><given-names>C</given-names></name>, <name><surname>Lai</surname><given-names>D</given-names></name>, <name><surname>Pfahles-Hutchens</surname><given-names>A</given-names></name>, <name><surname>Seed</surname><given-names>J</given-names></name>. <article-title>Perfluoroalkyl acids: a review of monitoring and toxicological findings</article-title>. <source>Toxicol Sci</source>. <year>2007</year>;<volume>99</volume>:<fpage>366</fpage>&#x02013;<lpage>94</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/toxsci/kfm128">10.1093/toxsci/kfm128</ext-link></comment>
<pub-id pub-id-type="pmid">17519394</pub-id></mixed-citation></ref><ref id="pmed.1002502.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Rosen</surname><given-names>MB</given-names></name>, <name><surname>Lee</surname><given-names>JS</given-names></name>, <name><surname>Ren</surname><given-names>H</given-names></name>, <name><surname>Vallanat</surname><given-names>B</given-names></name>, <name><surname>Liu</surname><given-names>J</given-names></name>, <name><surname>Waalkes</surname><given-names>MP</given-names></name>, <etal>et al</etal>
<article-title>Toxicogenomic dissection of the perfluorooctanoic acid transcript profile in mouse liver: evidence for the involvement of nuclear receptors PPAR alpha and CAR</article-title>. <source>Toxicol Sci</source>. <year>2008</year>;<volume>103</volume>:<fpage>46</fpage>&#x02013;<lpage>56</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/toxsci/kfn025">10.1093/toxsci/kfn025</ext-link></comment>
<pub-id pub-id-type="pmid">18281256</pub-id></mixed-citation></ref><ref id="pmed.1002502.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>Vanden Heuvel</surname><given-names>JP</given-names></name>, <name><surname>Thompson</surname><given-names>JT</given-names></name>, <name><surname>Frame</surname><given-names>SR</given-names></name>, <name><surname>Gillies</surname><given-names>PJ</given-names></name>. <article-title>Differential activation of nuclear receptors by perfluorinated fatty acid analogs and natural fatty acids: a comparison of human, mouse, and rat peroxisome proliferator-activated receptor-alpha, -beta, and -gamma, liver X receptor-beta, and retinoid X receptor-alpha</article-title>. <source>Toxicol Sci</source>. <year>2006</year>;<volume>92</volume>:<fpage>476</fpage>&#x02013;<lpage>89</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/toxsci/kfl014">10.1093/toxsci/kfl014</ext-link></comment>
<pub-id pub-id-type="pmid">16731579</pub-id></mixed-citation></ref><ref id="pmed.1002502.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Halldorsson</surname><given-names>TI</given-names></name>, <name><surname>Rytter</surname><given-names>D</given-names></name>, <name><surname>Haug</surname><given-names>LS</given-names></name>, <name><surname>Bech</surname><given-names>BH</given-names></name>, <name><surname>Danielsen</surname><given-names>I</given-names></name>, <name><surname>Becher</surname><given-names>G</given-names></name>, <etal>et al</etal>
<article-title>Prenatal exposure to perfluorooctanoate and risk of overweight at 20 years of age: a prospective cohort study</article-title>. <source>Environ Health Perspect</source>. <year>2012</year>;<volume>120</volume>:<fpage>668</fpage>&#x02013;<lpage>73</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1289/ehp.1104034">10.1289/ehp.1104034</ext-link></comment>
<pub-id pub-id-type="pmid">22306490</pub-id></mixed-citation></ref><ref id="pmed.1002502.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>Andersen</surname><given-names>CS</given-names></name>, <name><surname>Fei</surname><given-names>C</given-names></name>, <name><surname>Gamborg</surname><given-names>M</given-names></name>, <name><surname>Nohr</surname><given-names>EA</given-names></name>, <name><surname>Sorensen</surname><given-names>TI</given-names></name>, <name><surname>Olsen</surname><given-names>J</given-names></name>. <article-title>Prenatal exposures to perfluorinated chemicals and anthropometry at 7 years of age</article-title>. <source>Am J Epidemiol</source>. <year>2013</year>;<volume>178</volume>:<fpage>921</fpage>&#x02013;<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/aje/kwt057">10.1093/aje/kwt057</ext-link></comment>
<pub-id pub-id-type="pmid">23825166</pub-id></mixed-citation></ref><ref id="pmed.1002502.ref023"><label>23</label><mixed-citation publication-type="journal"><name><surname>Maisonet</surname><given-names>M</given-names></name>, <name><surname>Terrell</surname><given-names>ML</given-names></name>, <name><surname>McGeehin</surname><given-names>MA</given-names></name>, <name><surname>Christensen</surname><given-names>KY</given-names></name>, <name><surname>Holmes</surname><given-names>A</given-names></name>, <name><surname>Calafat</surname><given-names>AM</given-names></name>, <etal>et al</etal>
<article-title>Maternal concentrations of polyfluoroalkyl compounds during pregnancy and fetal and postnatal growth in British girls</article-title>. <source>Environ Health Perspect</source>. <year>2012</year>;<volume>120</volume>:<fpage>1432</fpage>&#x02013;<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1289/ehp.1003096">10.1289/ehp.1003096</ext-link></comment>
<pub-id pub-id-type="pmid">22935244</pub-id></mixed-citation></ref><ref id="pmed.1002502.ref024"><label>24</label><mixed-citation publication-type="journal"><name><surname>Braun</surname><given-names>JM</given-names></name>, <name><surname>Chen</surname><given-names>A</given-names></name>, <name><surname>Romano</surname><given-names>ME</given-names></name>, <name><surname>Calafat</surname><given-names>AM</given-names></name>, <name><surname>Webster</surname><given-names>GM</given-names></name>, <name><surname>Yolton</surname><given-names>K</given-names></name>, <etal>et al</etal>
<article-title>Prenatal perfluoroalkyl substance exposure and child adiposity at 8 years of age: the HOME study</article-title>. <source>Obesity (Silver Spring)</source>. <year>2016</year>;<volume>24</volume>:<fpage>231</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">26554535</pub-id></mixed-citation></ref><ref id="pmed.1002502.ref025"><label>25</label><mixed-citation publication-type="journal"><name><surname>Hoyer</surname><given-names>BB</given-names></name>, <name><surname>Ramlau-Hansen</surname><given-names>CH</given-names></name>, <name><surname>Vrijheid</surname><given-names>M</given-names></name>, <name><surname>Valvi</surname><given-names>D</given-names></name>, <name><surname>Pedersen</surname><given-names>HS</given-names></name>, <name><surname>Zviezdai</surname><given-names>V</given-names></name>, <etal>et al</etal>
<article-title>Anthropometry in 5- to 9-year-old Greenlandic and Ukrainian children in relation to prenatal exposure to perfluorinated alkyl substances</article-title>. <source>Environ Health Perspect</source>. <year>2015</year>;<volume>123</volume>:<fpage>841</fpage>&#x02013;<lpage>6</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1289/ehp.1408881">10.1289/ehp.1408881</ext-link></comment>
<pub-id pub-id-type="pmid">25809098</pub-id></mixed-citation></ref><ref id="pmed.1002502.ref026"><label>26</label><mixed-citation publication-type="journal"><name><surname>Mora</surname><given-names>AM</given-names></name>, <name><surname>Oken</surname><given-names>E</given-names></name>, <name><surname>Rifas-Shiman</surname><given-names>SL</given-names></name>, <name><surname>Webster</surname><given-names>TF</given-names></name>, <name><surname>Gillman</surname><given-names>MW</given-names></name>, <name><surname>Calafat</surname><given-names>AM</given-names></name>, <etal>et al</etal>
<article-title>Prenatal exposure to perfluoroalkyl substances and adiposity in early and mid-childhood</article-title>. <source>Environ Health Perspect</source>. <year>2017</year>;<volume>125</volume>:<fpage>467</fpage>&#x02013;<lpage>73</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1289/EHP246">10.1289/EHP246</ext-link></comment>
<pub-id pub-id-type="pmid">27352404</pub-id></mixed-citation></ref><ref id="pmed.1002502.ref027"><label>27</label><mixed-citation publication-type="journal"><name><surname>Karlsen</surname><given-names>M</given-names></name>, <name><surname>Grandjean</surname><given-names>P</given-names></name>, <name><surname>Weihe</surname><given-names>P</given-names></name>, <name><surname>Steuerwald</surname><given-names>U</given-names></name>, <name><surname>Oulhote</surname><given-names>Y</given-names></name>, <name><surname>Valvi</surname><given-names>D</given-names></name>. <article-title>Early-life exposures to persistent organic pollutants in relation to overweight in preschool children</article-title>. <source>Reprod Toxicol</source>. <year>2017</year>;<volume>68</volume>:<fpage>145</fpage>&#x02013;<lpage>53</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.reprotox.2016.08.002">10.1016/j.reprotox.2016.08.002</ext-link></comment>
<pub-id pub-id-type="pmid">27496715</pub-id></mixed-citation></ref><ref id="pmed.1002502.ref028"><label>28</label><mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>B</given-names></name>. <article-title>Thyroid hormone as a determinant of energy expenditure and the basal metabolic rate</article-title>. <source>Thyroid</source>. <year>2008</year>;<volume>18</volume>:<fpage>141</fpage>&#x02013;<lpage>4</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1089/thy.2007.0266">10.1089/thy.2007.0266</ext-link></comment>
<pub-id pub-id-type="pmid">18279014</pub-id></mixed-citation></ref><ref id="pmed.1002502.ref029"><label>29</label><mixed-citation publication-type="journal"><name><surname>Knox</surname><given-names>SS</given-names></name>, <name><surname>Jackson</surname><given-names>T</given-names></name>, <name><surname>Frisbee</surname><given-names>SJ</given-names></name>, <name><surname>Javins</surname><given-names>B</given-names></name>, <name><surname>Ducatman</surname><given-names>AM</given-names></name>. <article-title>Perfluorocarbon exposure, gender and thyroid function in the C8 Health Project</article-title>. <source>J Toxicol Sci</source>. <year>2011</year>;<volume>36</volume>:<fpage>403</fpage>&#x02013;<lpage>10</lpage>. <pub-id pub-id-type="pmid">21804304</pub-id></mixed-citation></ref><ref id="pmed.1002502.ref030"><label>30</label><mixed-citation publication-type="journal"><name><surname>Wen</surname><given-names>LL</given-names></name>, <name><surname>Lin</surname><given-names>LY</given-names></name>, <name><surname>Su</surname><given-names>TC</given-names></name>, <name><surname>Chen</surname><given-names>PC</given-names></name>, <name><surname>Lin</surname><given-names>CY</given-names></name>. <article-title>Association between serum perfluorinated chemicals and thyroid function in U.S. adults: the National Health and Nutrition Examination Survey 2007&#x02013;2010</article-title>. <source>J Clin Endocrinol Metab</source>. <year>2013</year>;<volume>98</volume>:<fpage>E1456</fpage>&#x02013;<lpage>64</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1210/jc.2013-1282">10.1210/jc.2013-1282</ext-link></comment>
<pub-id pub-id-type="pmid">23864701</pub-id></mixed-citation></ref><ref id="pmed.1002502.ref031"><label>31</label><mixed-citation publication-type="journal"><name><surname>Calafat</surname><given-names>AM</given-names></name>, <name><surname>Wong</surname><given-names>LY</given-names></name>, <name><surname>Kuklenyik</surname><given-names>Z</given-names></name>, <name><surname>Reidy</surname><given-names>JA</given-names></name>, <name><surname>Needham</surname><given-names>LL</given-names></name>. <article-title>Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003&#x02013;2004 and comparisons with NHANES 1999&#x02013;2000</article-title>. <source>Environ Health Perspect</source>. <year>2007</year>;<volume>115</volume>:<fpage>1596</fpage>&#x02013;<lpage>602</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1289/ehp.10598">10.1289/ehp.10598</ext-link></comment>
<pub-id pub-id-type="pmid">18007991</pub-id></mixed-citation></ref><ref id="pmed.1002502.ref032"><label>32</label><mixed-citation publication-type="journal"><name><surname>Schaider</surname><given-names>LA</given-names></name>, <name><surname>Balan</surname><given-names>SA</given-names></name>, <name><surname>Blum</surname><given-names>A</given-names></name>, <name><surname>Andrews</surname><given-names>DQ</given-names></name>, <name><surname>Strynar</surname><given-names>MJ</given-names></name>, <name><surname>Dickinson</surname><given-names>ME</given-names></name>, <etal>et al</etal>
<article-title>Fluorinated compounds in US fast food packaging</article-title>. <source>Environ Sci Technol Lett</source>. <year>2017</year>;<volume>4</volume>:<fpage>105</fpage>&#x02013;<lpage>11</lpage>.</mixed-citation></ref><ref id="pmed.1002502.ref033"><label>33</label><mixed-citation publication-type="journal"><name><surname>Begley</surname><given-names>TH</given-names></name>, <name><surname>White</surname><given-names>K</given-names></name>, <name><surname>Honigfort</surname><given-names>P</given-names></name>, <name><surname>Twaroski</surname><given-names>ML</given-names></name>, <name><surname>Neches</surname><given-names>R</given-names></name>, <name><surname>Walker</surname><given-names>RA</given-names></name>. <article-title>Perfluorochemicals: potential sources of and migration from food packaging</article-title>. <source>Food Addit Contam</source>. <year>2005</year>;<volume>22</volume>:<fpage>1023</fpage>&#x02013;<lpage>31</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1080/02652030500183474">10.1080/02652030500183474</ext-link></comment>
<pub-id pub-id-type="pmid">16227186</pub-id></mixed-citation></ref><ref id="pmed.1002502.ref034"><label>34</label><mixed-citation publication-type="journal"><name><surname>Fromme</surname><given-names>H</given-names></name>, <name><surname>Tittlemier</surname><given-names>SA</given-names></name>, <name><surname>Volkel</surname><given-names>W</given-names></name>, <name><surname>Wilhelm</surname><given-names>M</given-names></name>, <name><surname>Twardella</surname><given-names>D</given-names></name>. <article-title>Perfluorinated compounds&#x02014;exposure assessment for the general population in Western countries</article-title>. <source>Int J Hyg Environ Health</source>. <year>2009</year>;<volume>212</volume>:<fpage>239</fpage>&#x02013;<lpage>70</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ijheh.2008.04.007">10.1016/j.ijheh.2008.04.007</ext-link></comment>
<pub-id pub-id-type="pmid">18565792</pub-id></mixed-citation></ref><ref id="pmed.1002502.ref035"><label>35</label><mixed-citation publication-type="journal"><name><surname>Hu</surname><given-names>XC</given-names></name>, <name><surname>Andrews</surname><given-names>DQ</given-names></name>, <name><surname>Lindstrom</surname><given-names>AB</given-names></name>, <name><surname>Bruton</surname><given-names>TA</given-names></name>, <name><surname>Schaider</surname><given-names>LA</given-names></name>, <name><surname>Grandjean</surname><given-names>P</given-names></name>, <etal>et al</etal>
<article-title>Detection of poly- and perfluoroalkyl substances (PFASs) in U.S. drinking water linked to industrial sites, military fire training areas, and wastewater treatment plants</article-title>. <source>Environ Sci Technol Lett</source>. <year>2016</year>;<volume>3</volume>:<fpage>344</fpage>&#x02013;<lpage>50</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1021/acs.estlett.6b00260">10.1021/acs.estlett.6b00260</ext-link></comment>
<pub-id pub-id-type="pmid">27752509</pub-id></mixed-citation></ref><ref id="pmed.1002502.ref036"><label>36</label><mixed-citation publication-type="journal"><name><surname>Olsen</surname><given-names>GW</given-names></name>, <name><surname>Burris</surname><given-names>JM</given-names></name>, <name><surname>Ehresman</surname><given-names>DJ</given-names></name>, <name><surname>Froehlich</surname><given-names>JW</given-names></name>, <name><surname>Seacat</surname><given-names>AM</given-names></name>, <name><surname>Butenhoff</surname><given-names>JL</given-names></name>, <etal>et al</etal>
<article-title>Half-life of serum elimination of perfluorooctanesulfonate,perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers</article-title>. <source>Environ Health Perspect</source>. <year>2007</year>;<volume>115</volume>:<fpage>1298</fpage>&#x02013;<lpage>305</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1289/ehp.10009">10.1289/ehp.10009</ext-link></comment>
<pub-id pub-id-type="pmid">17805419</pub-id></mixed-citation></ref><ref id="pmed.1002502.ref037"><label>37</label><mixed-citation publication-type="journal"><name><surname>Sacks</surname><given-names>FM</given-names></name>, <name><surname>Bray</surname><given-names>GA</given-names></name>, <name><surname>Carey</surname><given-names>VJ</given-names></name>, <name><surname>Smith</surname><given-names>SR</given-names></name>, <name><surname>Ryan</surname><given-names>DH</given-names></name>, <name><surname>Anton</surname><given-names>SD</given-names></name>, <etal>et al</etal>
<article-title>Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates</article-title>. <source>N Engl J Med</source>. <year>2009</year>;<volume>360</volume>:<fpage>859</fpage>&#x02013;<lpage>73</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1056/NEJMoa0804748">10.1056/NEJMoa0804748</ext-link></comment>
<pub-id pub-id-type="pmid">19246357</pub-id></mixed-citation></ref><ref id="pmed.1002502.ref038"><label>38</label><mixed-citation publication-type="journal"><name><surname>Liu</surname><given-names>G</given-names></name>, <name><surname>Liang</surname><given-names>L</given-names></name>, <name><surname>Bray</surname><given-names>GA</given-names></name>, <name><surname>Qi</surname><given-names>L</given-names></name>, <name><surname>Hu</surname><given-names>FB</given-names></name>, <name><surname>Rood</surname><given-names>J</given-names></name>, <etal>et al</etal>
<article-title>Thyroid hormones and changes in body weight and metabolic parameters in response to weight-loss diets: the POUNDS LOST trial</article-title>. <source>Int J Obes (Lond)</source>. <year>2017</year>;<volume>41</volume>:<fpage>878</fpage>&#x02013;<lpage>86</lpage>.<pub-id pub-id-type="pmid">28138133</pub-id></mixed-citation></ref><ref id="pmed.1002502.ref039"><label>39</label><mixed-citation publication-type="journal"><name><surname>Tirosh</surname><given-names>A</given-names></name>, <name><surname>de Souza</surname><given-names>RJ</given-names></name>, <name><surname>Sacks</surname><given-names>F</given-names></name>, <name><surname>Bray</surname><given-names>GA</given-names></name>, <name><surname>Smith</surname><given-names>SR</given-names></name>, <name><surname>LeBoff</surname><given-names>MS</given-names></name>. <article-title>Sex differences in the effects of weight loss diets on bone mineral density and body composition: POUNDS LOST trial</article-title>. <source>J Clin Endocrinol Metab</source>. <year>2015</year>;<volume>100</volume>:<fpage>2463</fpage>&#x02013;<lpage>71</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1210/jc.2015-1050">10.1210/jc.2015-1050</ext-link></comment>
<pub-id pub-id-type="pmid">25825948</pub-id></mixed-citation></ref><ref id="pmed.1002502.ref040"><label>40</label><mixed-citation publication-type="journal"><name><surname>de Jonge</surname><given-names>L</given-names></name>, <name><surname>Bray</surname><given-names>GA</given-names></name>, <name><surname>Smith</surname><given-names>SR</given-names></name>, <name><surname>Ryan</surname><given-names>DH</given-names></name>, <name><surname>de Souza</surname><given-names>RJ</given-names></name>, <name><surname>Loria</surname><given-names>CM</given-names></name>, <etal>et al</etal>
<article-title>Effect of diet composition and weight loss on resting energy expenditure in the POUNDS LOST study</article-title>. <source>Obesity (Silver Spring)</source>. <year>2012</year>;<volume>20</volume>:<fpage>2384</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">22627912</pub-id></mixed-citation></ref><ref id="pmed.1002502.ref041"><label>41</label><mixed-citation publication-type="journal"><name><surname>Vestergaard</surname><given-names>S</given-names></name>, <name><surname>Nielsen</surname><given-names>F</given-names></name>, <name><surname>Andersson</surname><given-names>AM</given-names></name>, <name><surname>Hjollund</surname><given-names>NH</given-names></name>, <name><surname>Grandjean</surname><given-names>P</given-names></name>, <name><surname>Andersen</surname><given-names>HR</given-names></name>, <etal>et al</etal>
<article-title>Association between perfluorinated compounds and time to pregnancy in a prospective cohort of Danish couples attempting to conceive</article-title>. <source>Hum Reprod</source>. <year>2012</year>;<volume>27</volume>:<fpage>873</fpage>&#x02013;<lpage>80</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/humrep/der450">10.1093/humrep/der450</ext-link></comment>
<pub-id pub-id-type="pmid">22246448</pub-id></mixed-citation></ref><ref id="pmed.1002502.ref042"><label>42</label><mixed-citation publication-type="journal"><name><surname>Levy</surname><given-names>JC</given-names></name>, <name><surname>Matthews</surname><given-names>DR</given-names></name>, <name><surname>Hermans</surname><given-names>MP</given-names></name>. <article-title>Correct homeostasis model assessment (HOMA) evaluation uses the computer program</article-title>. <source>Diabetes Care</source>. <year>1998</year>;<volume>21</volume>:<fpage>2191</fpage>&#x02013;<lpage>2</lpage>. <pub-id pub-id-type="pmid">9839117</pub-id></mixed-citation></ref><ref id="pmed.1002502.ref043"><label>43</label><mixed-citation publication-type="journal"><name><surname>Baecke</surname><given-names>JA</given-names></name>, <name><surname>Burema</surname><given-names>J</given-names></name>, <name><surname>Frijters</surname><given-names>JE</given-names></name>. <article-title>A short questionnaire for the measurement of habitual physical activity in epidemiological studies</article-title>. <source>Am J Clin Nutr</source>. <year>1982</year>;<volume>36</volume>:<fpage>936</fpage>&#x02013;<lpage>42</lpage>. <pub-id pub-id-type="pmid">7137077</pub-id></mixed-citation></ref><ref id="pmed.1002502.ref044"><label>44</label><mixed-citation publication-type="journal"><name><surname>Nelson</surname><given-names>JW</given-names></name>, <name><surname>Hatch</surname><given-names>EE</given-names></name>, <name><surname>Webster</surname><given-names>TF</given-names></name>. <article-title>Exposure to polyfluoroalkyl chemicals and cholesterol, body weight, and insulin resistance in the general U.S. population</article-title>. <source>Environ Health Perspect</source>. <year>2010</year>;<volume>118</volume>:<fpage>197</fpage>&#x02013;<lpage>202</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1289/ehp.0901165">10.1289/ehp.0901165</ext-link></comment>
<pub-id pub-id-type="pmid">20123614</pub-id></mixed-citation></ref><ref id="pmed.1002502.ref045"><label>45</label><mixed-citation publication-type="journal"><name><surname>Jain</surname><given-names>RB</given-names></name>. <article-title>Contribution of diet and other factors to the levels of selected polyfluorinated compounds: data from NHANES 2003&#x02013;2008</article-title>. <source>Int J Hyg Environ Health</source>. <year>2014</year>;<volume>217</volume>:<fpage>52</fpage>&#x02013;<lpage>61</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ijheh.2013.03.008">10.1016/j.ijheh.2013.03.008</ext-link></comment>
<pub-id pub-id-type="pmid">23601780</pub-id></mixed-citation></ref><ref id="pmed.1002502.ref046"><label>46</label><mixed-citation publication-type="journal"><name><surname>Lin</surname><given-names>CY</given-names></name>, <name><surname>Chen</surname><given-names>PC</given-names></name>, <name><surname>Lin</surname><given-names>YC</given-names></name>, <name><surname>Lin</surname><given-names>LY</given-names></name>. <article-title>Association among serum perfluoroalkyl chemicals, glucose homeostasis, and metabolic syndrome in adolescents and adults</article-title>. <source>Diabetes Care</source>. <year>2009</year>;<volume>32</volume>:<fpage>702</fpage>&#x02013;<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.2337/dc08-1816">10.2337/dc08-1816</ext-link></comment>
<pub-id pub-id-type="pmid">19114613</pub-id></mixed-citation></ref><ref id="pmed.1002502.ref047"><label>47</label><mixed-citation publication-type="journal"><name><surname>Timmermann</surname><given-names>CA</given-names></name>, <name><surname>Rossing</surname><given-names>LI</given-names></name>, <name><surname>Grontved</surname><given-names>A</given-names></name>, <name><surname>Ried-Larsen</surname><given-names>M</given-names></name>, <name><surname>Dalgard</surname><given-names>C</given-names></name>, <name><surname>Andersen</surname><given-names>LB</given-names></name>, <etal>et al</etal>
<article-title>Adiposity and glycemic control in children exposed to perfluorinated compounds</article-title>. <source>J Clin Endocrinol Metab</source>. <year>2014</year>;<volume>99</volume>:<fpage>E608</fpage>&#x02013;<lpage>14</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1210/jc.2013-3460">10.1210/jc.2013-3460</ext-link></comment>
<pub-id pub-id-type="pmid">24606078</pub-id></mixed-citation></ref><ref id="pmed.1002502.ref048"><label>48</label><mixed-citation publication-type="journal"><name><surname>Domazet</surname><given-names>SL</given-names></name>, <name><surname>Grontved</surname><given-names>A</given-names></name>, <name><surname>Timmermann</surname><given-names>AG</given-names></name>, <name><surname>Nielsen</surname><given-names>F</given-names></name>, <name><surname>Jensen</surname><given-names>TK</given-names></name>. <article-title>Longitudinal associations of exposure to perfluoroalkylated substances in childhood and adolescence and indicators of adiposity and glucose metabolism 6 and 12 years later: the European Youth Heart Study</article-title>. <source>Diabetes Care</source>. <year>2016</year>;<volume>39</volume>:<fpage>1745</fpage>&#x02013;<lpage>51</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.2337/dc16-0269">10.2337/dc16-0269</ext-link></comment>
<pub-id pub-id-type="pmid">27489335</pub-id></mixed-citation></ref><ref id="pmed.1002502.ref049"><label>49</label><mixed-citation publication-type="journal"><name><surname>Barry</surname><given-names>V</given-names></name>, <name><surname>Darrow</surname><given-names>LA</given-names></name>, <name><surname>Klein</surname><given-names>M</given-names></name>, <name><surname>Winquist</surname><given-names>A</given-names></name>, <name><surname>Steenland</surname><given-names>K</given-names></name>. <article-title>Early life perfluorooctanoic acid (PFOA) exposure and overweight and obesity risk in adulthood in a community with elevated exposure</article-title>. <source>Environ Res</source>. <year>2014</year>;<volume>132</volume>:<fpage>62</fpage>&#x02013;<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.envres.2014.03.025">10.1016/j.envres.2014.03.025</ext-link></comment>
<pub-id pub-id-type="pmid">24742729</pub-id></mixed-citation></ref><ref id="pmed.1002502.ref050"><label>50</label><mixed-citation publication-type="journal"><name><surname>Liu</surname><given-names>RC</given-names></name>, <name><surname>Hahn</surname><given-names>C</given-names></name>, <name><surname>Hurtt</surname><given-names>ME</given-names></name>. <article-title>The direct effect of hepatic peroxisome proliferators on rat Leydig cell function in vitro</article-title>. <source>Fundam Appl Toxicol</source>. <year>1996</year>;<volume>30</volume>:<fpage>102</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="pmid">8812244</pub-id></mixed-citation></ref><ref id="pmed.1002502.ref051"><label>51</label><mixed-citation publication-type="journal"><name><surname>Benninghoff</surname><given-names>AD</given-names></name>, <name><surname>Bisson</surname><given-names>WH</given-names></name>, <name><surname>Koch</surname><given-names>DC</given-names></name>, <name><surname>Ehresman</surname><given-names>DJ</given-names></name>, <name><surname>Kolluri</surname><given-names>SK</given-names></name>, <name><surname>Williams</surname><given-names>DE</given-names></name>. <article-title>Estrogen-like activity of perfluoroalkyl acids in vivo and interaction with human and rainbow trout estrogen receptors in vitro</article-title>. <source>Toxicol Sci</source>. <year>2011</year>;<volume>120</volume>:<fpage>42</fpage>&#x02013;<lpage>58</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/toxsci/kfq379">10.1093/toxsci/kfq379</ext-link></comment>
<pub-id pub-id-type="pmid">21163906</pub-id></mixed-citation></ref><ref id="pmed.1002502.ref052"><label>52</label><mixed-citation publication-type="journal"><name><surname>Cunningham</surname><given-names>JJ</given-names></name>. <article-title>Body composition as a determinant of energy expenditure: a synthetic review and a proposed general prediction equation</article-title>. <source>Am J Clin Nutr</source>. <year>1991</year>;<volume>54</volume>:<fpage>963</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="pmid">1957828</pub-id></mixed-citation></ref><ref id="pmed.1002502.ref053"><label>53</label><mixed-citation publication-type="journal"><name><surname>Post</surname><given-names>GB</given-names></name>, <name><surname>Cohn</surname><given-names>PD</given-names></name>, <name><surname>Cooper</surname><given-names>KR</given-names></name>. <article-title>Perfluorooctanoic acid (PFOA), an emerging drinking water contaminant: a critical review of recent literature</article-title>. <source>Environ Res</source>. <year>2012</year>;<volume>116</volume>:<fpage>93</fpage>&#x02013;<lpage>117</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.envres.2012.03.007">10.1016/j.envres.2012.03.007</ext-link></comment>
<pub-id pub-id-type="pmid">22560884</pub-id></mixed-citation></ref><ref id="pmed.1002502.ref054"><label>54</label><mixed-citation publication-type="journal"><name><surname>Evans</surname><given-names>RM</given-names></name>, <name><surname>Barish</surname><given-names>GD</given-names></name>, <name><surname>Wang</surname><given-names>YX</given-names></name>. <article-title>PPARs and the complex journey to obesity</article-title>. <source>Nat Med</source>. <year>2004</year>;<volume>10</volume>:<fpage>355</fpage>&#x02013;<lpage>61</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nm1025">10.1038/nm1025</ext-link></comment>
<pub-id pub-id-type="pmid">15057233</pub-id></mixed-citation></ref><ref id="pmed.1002502.ref055"><label>55</label><mixed-citation publication-type="journal"><name><surname>Scharmach</surname><given-names>E</given-names></name>, <name><surname>Buhrke</surname><given-names>T</given-names></name>, <name><surname>Lichtenstein</surname><given-names>D</given-names></name>, <name><surname>Lampen</surname><given-names>A</given-names></name>. <article-title>Perfluorooctanoic acid affects the activity of the hepatocyte nuclear factor 4 alpha (HNF4alpha)</article-title>. <source>Toxicol Lett</source>. <year>2012</year>;<volume>212</volume>:<fpage>106</fpage>&#x02013;<lpage>12</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.toxlet.2012.05.007">10.1016/j.toxlet.2012.05.007</ext-link></comment>
<pub-id pub-id-type="pmid">22609092</pub-id></mixed-citation></ref><ref id="pmed.1002502.ref056"><label>56</label><mixed-citation publication-type="journal"><name><surname>Hayhurst</surname><given-names>GP</given-names></name>, <name><surname>Lee</surname><given-names>YH</given-names></name>, <name><surname>Lambert</surname><given-names>G</given-names></name>, <name><surname>Ward</surname><given-names>JM</given-names></name>, <name><surname>Gonzalez</surname><given-names>FJ</given-names></name>. <article-title>Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis</article-title>. <source>Mol Cell Biol</source>. <year>2001</year>;<volume>21</volume>:<fpage>1393</fpage>&#x02013;<lpage>403</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/MCB.21.4.1393-1403.2001">10.1128/MCB.21.4.1393-1403.2001</ext-link></comment>
<pub-id pub-id-type="pmid">11158324</pub-id></mixed-citation></ref><ref id="pmed.1002502.ref057"><label>57</label><mixed-citation publication-type="journal"><name><surname>Long</surname><given-names>M</given-names></name>, <name><surname>Ghisari</surname><given-names>M</given-names></name>, <name><surname>Bonefeld-Jorgensen</surname><given-names>EC</given-names></name>. <article-title>Effects of perfluoroalkyl acids on the function of the thyroid hormone and the aryl hydrocarbon receptor</article-title>. <source>Environ Sci Pollut Res Int</source>. <year>2013</year>;<volume>20</volume>:<fpage>8045</fpage>&#x02013;<lpage>56</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s11356-013-1628-7">10.1007/s11356-013-1628-7</ext-link></comment>
<pub-id pub-id-type="pmid">23539207</pub-id></mixed-citation></ref><ref id="pmed.1002502.ref058"><label>58</label><mixed-citation publication-type="journal"><name><surname>Ravussin</surname><given-names>E</given-names></name>, <name><surname>Lillioja</surname><given-names>S</given-names></name>, <name><surname>Knowler</surname><given-names>WC</given-names></name>, <name><surname>Christin</surname><given-names>L</given-names></name>, <name><surname>Freymond</surname><given-names>D</given-names></name>, <name><surname>Abbott</surname><given-names>WG</given-names></name>, <etal>et al</etal>
<article-title>Reduced rate of energy expenditure as a risk factor for body-weight gain</article-title>. <source>N Engl J Med</source>. <year>1988</year>;<volume>318</volume>:<fpage>467</fpage>&#x02013;<lpage>72</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1056/NEJM198802253180802">10.1056/NEJM198802253180802</ext-link></comment>
<pub-id pub-id-type="pmid">3340128</pub-id></mixed-citation></ref><ref id="pmed.1002502.ref059"><label>59</label><mixed-citation publication-type="journal"><name><surname>Mullur</surname><given-names>R</given-names></name>, <name><surname>Liu</surname><given-names>YY</given-names></name>, <name><surname>Brent</surname><given-names>GA</given-names></name>. <article-title>Thyroid hormone regulation of metabolism</article-title>. <source>Physiol Rev</source>. <year>2014</year>;<volume>94</volume>:<fpage>355</fpage>&#x02013;<lpage>82</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/physrev.00030.2013">10.1152/physrev.00030.2013</ext-link></comment>
<pub-id pub-id-type="pmid">24692351</pub-id></mixed-citation></ref><ref id="pmed.1002502.ref060"><label>60</label><mixed-citation publication-type="journal"><name><surname>Conder</surname><given-names>JM</given-names></name>, <name><surname>Hoke</surname><given-names>RA</given-names></name>, <name><surname>De Wolf</surname><given-names>W</given-names></name>, <name><surname>Russell</surname><given-names>MH</given-names></name>, <name><surname>Buck</surname><given-names>RC</given-names></name>. <article-title>Are PFCAs bioaccumulative? A critical review and comparison with regulatory criteria and persistent lipophilic compounds</article-title>. <source>Environ Sci Technol</source>. <year>2008</year>;<volume>42</volume>:<fpage>995</fpage>&#x02013;<lpage>1003</lpage>. <pub-id pub-id-type="pmid">18351063</pub-id></mixed-citation></ref><ref id="pmed.1002502.ref061"><label>61</label><mixed-citation publication-type="journal"><name><surname>Cummings</surname><given-names>DE</given-names></name>, <name><surname>Weigle</surname><given-names>DS</given-names></name>, <name><surname>Frayo</surname><given-names>RS</given-names></name>, <name><surname>Breen</surname><given-names>PA</given-names></name>, <name><surname>Ma</surname><given-names>MK</given-names></name>, <name><surname>Dellinger</surname><given-names>EP</given-names></name>, <etal>et al</etal>
<article-title>Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery</article-title>. <source>N Engl J Med</source>. <year>2002</year>;<volume>346</volume>:<fpage>1623</fpage>&#x02013;<lpage>30</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1056/NEJMoa012908">10.1056/NEJMoa012908</ext-link></comment>
<pub-id pub-id-type="pmid">12023994</pub-id></mixed-citation></ref><ref id="pmed.1002502.ref062"><label>62</label><mixed-citation publication-type="journal"><name><surname>Richardson</surname><given-names>MT</given-names></name>, <name><surname>Ainsworth</surname><given-names>BE</given-names></name>, <name><surname>Wu</surname><given-names>HC</given-names></name>, <name><surname>Jacobs</surname><given-names>DR</given-names><suffix>Jr</suffix></name>, <name><surname>Leon</surname><given-names>AS</given-names></name>. <article-title>Ability of the Atherosclerosis Risk in Communities (ARIC)/Baecke Questionnaire to assess leisure-time physical activity</article-title>. <source>Int J Epidemiol</source>. <year>1995</year>;<volume>24</volume>:<fpage>685</fpage>&#x02013;<lpage>93</lpage>. <pub-id pub-id-type="pmid">8550264</pub-id></mixed-citation></ref><ref id="pmed.1002502.ref063"><label>63</label><mixed-citation publication-type="other">US Environmental Protection Agency. 2010/2015 PFOA stewardship program. Washington (DC): US Environmental Protection Agency; 2006.</mixed-citation></ref><ref id="pmed.1002502.ref064"><label>64</label><mixed-citation publication-type="journal"><name><surname>Kato</surname><given-names>K</given-names></name>, <name><surname>Wong</surname><given-names>LY</given-names></name>, <name><surname>Jia</surname><given-names>LT</given-names></name>, <name><surname>Kuklenyik</surname><given-names>Z</given-names></name>, <name><surname>Calafat</surname><given-names>AM</given-names></name>. <article-title>Trends in exposure to polyfluoroalkyl chemicals in the U.S. Population: 1999&#x02013;2008</article-title>. <source>Environ Sci Technol</source>. <year>2011</year>;<volume>45</volume>:<fpage>8037</fpage>&#x02013;<lpage>45</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1021/es1043613">10.1021/es1043613</ext-link></comment>
<pub-id pub-id-type="pmid">21469664</pub-id></mixed-citation></ref></ref-list></back></article>